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ABSTRACT 
Objective: Vitamin and mineral supplements have been increasingly available for decades. The 
increase in availability of supplements and their use in combination with prescription drugs 
suggests that the risk of an adverse drug-nutrient interaction has drastically increased. This is 
especially concerning in populations with greater medication use. The purpose of this study was 
to assess vitamin and mineral supplement use in older adults with complex medication use to 
identify supplement use, overuse, and use from multiple sources. A secondary outcome of this 
study was to assess the potential for adverse drug-nutrient interactions in medically complex 
patients. Methods: A retrospective chart review was completed on 229 medically-complex 
patients 50 years of age and older who had new assessments of medications completed between 
January 2014 and January 19th, 2017 at the University of Saskatchewan Medication Assessment 
Centre. Results: Data indicate that 76.9% (n = 176) of patients (mean: 69 years) reported using ≥ 
1 vitamin and/or mineral supplement daily. Total product count (oral prescriptions, over-the-
counter (OTC) products, dietary supplements) ranged from 1-45 per day, with a mean 9.8 and 
median of 9. The tolerable upper intake level (UL) for nutrients was exceeded by 39.7% (n = 70) 
of reported supplement users (n = 176). One case exceeded the UL for 6 different nutrients, from 
supplemental intake alone. Of reported supplement users, 43.2% consumed supplemental 
nutrients from more than one source, which was significantly associated (p < 0.001) with 
supplemental nutrient intake at or above the UL. Conclusions: Vitamin and mineral supplement 
use in conjunction with prescription drugs and OTC products was observed in this population, 
with reported intake of many supplemental nutrients that exceeded the UL. 
 iv 
 
ACKNOWLEDGEMENTS 
 This study and the completion of my Master’s degree would not have been possible 
without the dedication of my supervisor, Dr. Susan Whiting. Susan, your guidance and support 
throughout my Master’s was admirable. I’d also like to thank Dr. Derek Jorgenson for agreeing 
to sit on my committee and allow us to work with The Medication Assessment Centre for the 
completion of this study. Dr. Phyllis Paterson, thank you for agreeing to chair my committee and 
provide advice and support along the way. Thank you to Eric Landry and Katherine Lysak at the 
Medication Assessment Centre for their support and education on the Electronic Medical 
Records and for answering all of my pharmacy-related questions. This study was supported by 
the Canada Graduate Scholarship – Master’s program from the Canadian Institutes of Health 
Research (CIHR), the College of Pharmacy and Nutrition at the University of Saskatchewan, and 
the University of Saskatchewan Irwin grant. I am likewise grateful for the many other 
distinctions that I received throughout my Master’s degree including scholarships and awards. 
Lastly, thank you to my family and dear friends who endlessly support my educational 
endeavors.   
 v 
 
TABLE OF CONTENTS 
Permission To Use ........................................................................................................................... i 
Disclaimer ....................................................................................................................................... ii 
ABSTRACT ................................................................................................................................... iii 
Acknowledgements ........................................................................................................................ iv 
Table of Contents ............................................................................................................................ v 
List of Tables ................................................................................................................................. ix 
List of Figures ................................................................................................................................ xi 
List of Abbreviations .................................................................................................................... xii 
List of Appendices ....................................................................................................................... xiii 
Chapter 1 ......................................................................................................................................... 1 
Introduction ................................................................................................................................. 1 
1.1 Background ........................................................................................................................... 1 
1.2 Rationale................................................................................................................................ 2 
1.3 Study Purpose and Objectives ............................................................................................... 3 
Chapter 2 ......................................................................................................................................... 4 
Literature Review ........................................................................................................................ 4 
2.1 Nutrition and Aging .............................................................................................................. 4 
 vi 
 
2.2 Nutrition Supplement Use by Older Adults .......................................................................... 6 
2.3 Dietary Reference Intakes ................................................................................................... 11 
2.4 Safety ................................................................................................................................... 14 
2.4.1 Polypharmacy ............................................................................................................... 15 
2.4.2 Drug-Nutrient Interactions ........................................................................................... 18 
Chapter 3 ....................................................................................................................................... 22 
Scoping Review......................................................................................................................... 22 
3.1 Abstract ............................................................................................................................... 22 
3.2 Introduction ......................................................................................................................... 23 
3.3 Background ......................................................................................................................... 23 
3.4 Description of Subject ......................................................................................................... 24 
3.5 Methods ............................................................................................................................... 25 
3.6 Results ................................................................................................................................. 32 
3.6.1 General Use of Vitamin and Mineral Supplements ...................................................... 32 
3.6.2 Specific Vitamin and Mineral Supplement Use ........................................................... 33 
3.7 Discussion ........................................................................................................................... 35 
3.8 Limitations .......................................................................................................................... 38 
3.9 Implications for Practice ..................................................................................................... 38 
3.10 Conclusion ......................................................................................................................... 39 
Chapter 4 ....................................................................................................................................... 40 
 vii 
 
Methodology ............................................................................................................................. 40 
4.1 Study Purpose ...................................................................................................................... 40 
4.2 Research Design .................................................................................................................. 40 
4.3 Research Plan ...................................................................................................................... 41 
4.4 Sample Selection ................................................................................................................. 43 
4.5 Statistical Analysis .............................................................................................................. 43 
4.6 Ethics Approval ................................................................................................................... 44 
Chapter 5 ....................................................................................................................................... 45 
Results ....................................................................................................................................... 45 
5.1 Demographic Data............................................................................................................... 45 
5.2 Use of Vitamin and Mineral Supplements .......................................................................... 46 
5.2.1 Supplemental Vitamin D .............................................................................................. 48 
5.3 Overuse of vitamin and mineral supplements ..................................................................... 49 
5.4 Vitamin and Mineral Supplement Use from Multiple Sources ........................................... 51 
5.5 Potential Drug-Nutrient Interactions ................................................................................... 52 
Chapter 6 ....................................................................................................................................... 59 
Discussion ................................................................................................................................. 59 
6.1 Discussion ........................................................................................................................... 59 
6.1.1 Demographics ............................................................................................................... 59 
6.1.2 Vitamin and Mineral Supplement Use ......................................................................... 61 
 viii 
 
6.1.3 Overuse of Vitamin and Mineral Supplements ............................................................ 62 
6.1.4 Vitamin and Mineral Supplement Use from Multiple Sources .................................... 68 
6.1.5 Potential Drug-Nutrient Interactions ............................................................................ 69 
6.2 Limitations .......................................................................................................................... 73 
6.3 Conclusion ........................................................................................................................... 74 
6.4 Future Research ................................................................................................................... 74 
6.5 Implications for Practice ................................................................................................ 75 
Chapter 7 ....................................................................................................................................... 76 
References ................................................................................................................................. 76 
Appendix A ................................................................................................................................... 87 
 
 
 
 ix 
 
LIST OF TABLES 
Table 2.1: Summary of changes to nutrient requirements for older adults (> 50 y) ........................6 
Table 2.2: Prevalence of Vitamin Mineral Supplement Use .........................................................11 
Table 2.3: Criteria Used to Set Tolerable Upper-Intake Levels (ULs)  .........................................13 
Table 2.4: Prevalence of Canadian adults (% (SE)) exceeding the UL from diet + supplement ...15 
Table 2.5: Summary of a Study of Patients Receiving Medication Assessments (n = 173)  ........17 
Table 2.6: Classification of Drug-Nutrient Interactions ................................................................18 
Table 2.7: Potential Drug-Nutrient Interactions ............................................................................20 
Table 2.8: Potential Nutrient-Drug Interactions ............................................................................21 
Table 3.1: List of terms searched in Medline and Embase databases ............................................25 
Table 3.2: Studies reporting on general supplement use in community-dwelling adults ..............27 
Table 3.3: Studies reporting on specific supplement use in community-dwelling adults .............28 
Table 4.1: Brand name formulations used for data when specific brand not available in chart ....42 
Table 5.1: Summary of Demographics and Product Usage ...........................................................45 
Table 5.2: Vitamin and/or mineral supplement (VMS) use by different population variables .....47 
Table 5.3: Associations between supplement use and patient characteristics ...............................48 
Table 5.4: Supplemental vitamin D use by population variables ..................................................49 
 x 
 
Table 5.5: Overuse of supplemental nutrients by reported supplement users ...............................50 
Table 5.6: Summary of potential drug-nutrient interactions from 4 case studies  .........................53 
Table 5.7: Case #1 of potential drug-nutrient interactions ............................................................54 
Table 5.8: Case #2 of potential drug-nutrient interactions ............................................................55 
Table 5.9: Case #3 of potential drug-nutrient interactions ............................................................57 
Table 5.10: Case #4 of potential drug-nutrient interactions ..........................................................58 
 
  
 xi 
 
LIST OF FIGURES 
Figure 3.1: Scoping review flow chart of searches, inclusions, and exclusions ............................31  
 xii 
 
LIST OF ABBREVIATIONS 
AI   Adequate Intake 
CCHS   Canadian Community Health Survey 
CCHS-HA  Canadian Community Health Survey-Healthy Aging 
DIN   Drug Identification Number 
DRI   Dietary Reference Intakes 
EAR   Estimated Average Requirement 
EMR   Electronic Medical Records 
GERD   Gastroesophageal reflux disease 
GI   Gastrointestinal  
LOAEL  Lowest observed adverse effect level 
LTC   Long Term Care 
MAC   Medication Assessment Centre 
MVM   Multivitamin/mineral 
NHP   Natural Health Product 
NOAEL  No observed adverse effect level 
NVM   Non-vitamin/mineral 
OTC   Over-the-counter 
PPI   Proton Pump Inhibitor 
RDA   Recommended Dietary Allowance  
REB   Research Ethics Board 
UL   Tolerable Upper-Intake Level 
VMS   Vitamin/Mineral Supplement 
 
 xiii 
 
LIST OF APPENDICES 
Appendix A. Data Extraction Form………..…….………………………………………………87 
 
 
 1 
 
CHAPTER 1 
INTRODUCTION 
1.1 Background 
Dietary supplements have been available to consumers for decades. In recent years, 
consumers have seen an increase in the variety of dietary supplements that are available for 
purchase and have increased their use of supplements (Health Canada, 2011; Qato, Wilder, 
Schumm, Gillet, & Alexander, 2016). The increase in available supplements and in use of dietary 
supplements in combination with prescription drugs suggests that the risk of an adverse drug-
nutrient interaction has drastically increased (Health Canada, 2011). This is especially 
concerning in populations with a higher complexity of medication usage, such as adults over the 
age of 50 years with morbidities. Previous Canadian nutrition research for this age group has 
focused on individuals in long term care and acute care settings (Ginter et al., 2013; Goorang, 
Ausman, Houser, & Whiting, 2015; Goorang, Thorpe, Bailod, & Whiting, 2015; Viveky et al., 
2012); thus, the gap in literature for this age group is identified as community dwelling adults 
over the age of 50. Dr. Whiting’s group has shown that individuals who take more medications 
and are at risk of undernutrition may benefit from using vitamin and/or mineral supplements but 
recognized that alternatively, too much nutrient supplementation can cause adverse drug-nutrient 
interactions and intake exceeding the Tolerable Upper Intake Level (UL) of some supplements 
(Ginter et al., 2013; Goorang, Ausman, et al., 2015; Goorang, Thorpe, et al., 2015; Greene-
Finestone, Langlois, & Whiting, 2013; Vatanparast, Adolphe, & Whiting, 2010; Viveky et al., 
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2012; Whiting, 2009). Further, few studies of medication use in older adults assessed the impact 
of dietary supplement use on medication functionality and overall nutrition status.  
The Medication Assessment Centre (MAC) at the University of Saskatchewan is a unique 
and evolving clinic that is run by faculty in the College of Pharmacy and Nutrition and offers in-
depth medication assessments for patients with complex medication needs. Additionally, the 
MAC is a teaching clinic where pharmacy students have the opportunity for early counselling 
exposure. A retrospective chart audit of 173 MAC patients showed an average age of 64.8 years 
and an average medication use of 13.8 drugs (including supplements and non-prescription 
products) per person (Jorgenson, Landry, & Lysak, 2016). Currently, to our knowledge, no 
published research into the specifics of potential adverse dietary supplement-drug interactions 
exists for this population, which is known to take many types of medications  (Jorgenson et al., 
2016).  
1.2 Rationale  
 This research project aimed to identify initial data needed to implement nutritional 
interventions, particularly to ensure the safe usage of vitamin and mineral supplements at the 
primary care level. Such nutritional interventions would aid in improving health status of older 
adults, especially those with chronic disease. In addition, this project sought to highlight the 
positive attributes that a collaborative interdisciplinary approach could bring to a pharmacist-led 
medication assessment centre, such as the integration of a dietitian into the assessment and 
counselling of medically-complex patients.  
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1.3 Study Purpose and Objectives 
 The purpose of this study was to assess the personal vitamin and mineral supplement use 
of older adults with complex medication use. Specifically, the three objectives were to: 1) 
identify use and overuse of vitamin and mineral supplements; 2) learn the extent to which people 
were consuming supplemental nutrients from multiple sources; 3) investigate the potential for 
adverse drug-nutrient interactions.  
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Nutrition and Aging  
According to the United Nations, the population of older adults (> 60 y) has been steadily 
increasing over time and is expected to rapidly increase over the coming years (United 
Nations  Population Division, 2015). In general, both physical activity and basal metabolic rate 
decrease with age, lending to a decrease in appetite and total energy intake, which can cause 
micronutrient deficiencies (Denny, 2008; Kirkpatrick & Tarasuk, 2008). Research also shows 
that older adults are at a higher risk of undernutrition secondary to a decrease in mobility, poor 
oral health, and morbidities (Denny, 2008). Physiologically, a decrease in kidney function and 
other age-related declines are more likely to affect nutrient absorption in older adults (Otten, 
Pitzi Hellwig, & Meyers, 2006). In order to meet recommended nutrient needs through later 
years in life, some people require a vitamin and mineral supplement in addition to their dietary 
intake.  
Recent analysis of data from a large population-based survey in Canada found that 
approximately one third (34%; n = 979,000) of older adults (≥ 65 years) in Canada were 
classified as being at nutritional risk in 2008/2009 (Ramage-Morin, Gilmour, & Rotermann, 
2017). Data from the Canadian Community Health Survey-Healthy Aging (CCHS-HA) that was 
completed in 2008/2009 was linked with hospital discharge and mortality data to evaluate the 
estimated nutritional risk, hospitalization, and mortality of older (≥ 65 years) community-
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dwelling Canadians (Ramage-Morin et al., 2017). Further, data from this study indicate that 
nutritional risk in older community-dwelling Canadian adults was independently associated with 
both hospitalization and mortality (Ramage-Morin et al., 2017). Seniors who were at nutritional 
risk had a significantly higher rate (31%) of hospitalization when compared to seniors in the 
same age group who were not considered to be at nutritional risk (24%) (Ramage-Morin et al., 
2017). Overall, the results of this survey reinforce the importance of nutritional adequacy in 
older adults.   
As we transition through different life stages, our requirements for various nutrients may 
increase or decrease due to physiological changes associated with the aging process, as 
summarized in Table 2.1. For adults 70 years of age and older, the Recommended Dietary 
Allowance (RDA) for vitamin D increases to 800 IU/day and all adults over the age of 50 years 
are recommended to take 400 IU/day of supplemental vitamin D as it rarely feasible to obtain 
sufficient vitamin D intake from food sources alone (Hanley et al., 2010; Health Canada, 2012; 
Ross, Taylor, Yaktine, & Del Valle, 2011). The key factor in determining an appropriate intake 
level for vitamin D in those over the age of 50 years is the risk for bone fracture (Ross et al., 
2011). Similar to vitamin D, the recommended increase in calcium intake with age is 
predominately related to fracture risk, which is of concern at an earlier age for woman (over 50 
years) compared to men (over 70 years) (Ross et al., 2011). A vitamin B12 supplement or 
consumption of B12 fortified foods is recommended for adults over the age of 50 years due to a 
likely decrease in gastric acidity and thus, a decrease in food-bound vitamin B12 absorption 
(Otten et al., 2006).   
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Table 2.1: Summary of changes to nutrient requirements* for older adults (> 50 y) 
Nutrient Change 
Vitamins 
     Vitamin D 
     Vitamin B6 
     Vitamin B12 
 
Increase (>70 y) 
Increase 
Supplement recommended 
Minerals 
     Calcium 
     Chromium 
     Iron 
     Sodium 
     Chloride 
 
Increase 
Decrease 
Decrease (Women) 
Decrease 
Decrease 
*(Otten et al., 2006; Ross et al., 2011)  
 
2.2 Nutritional Supplement Use by Older Adults 
 ‘Dietary supplement’ is a broad term commonly used and represents a lack of 
homogeneity in the literature. Scholars define ‘dietary supplement’ as: all supplements 
(including vitamin and minerals) or all supplements (excluding vitamins and minerals). This 
literature review revealed a lack of recent studies investigating vitamin and mineral supplement 
use in community-dwelling adults over the age of 50. In Canada, vitamin and mineral 
supplements are considered to be Natural Health Products (NHPs) and are the most commonly 
used NHPs (Health Canada, 2011). 
Detailed dietary supplement use by older adults has been studied in Canadian Long-Term 
Care (LTC) facilities but less so for older adults living in the community. To this extent, a 
scoping review of vitamin and mineral supplement use by community-dwelling adults in both 
Canada and the United States was conducted and the manuscript can be found in Chapter 3. 
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Overall, few Canadian studies have investigated the use and safety of vitamin and mineral 
supplements in community-dwelling adults over the age of 50 and the majority of studies 
focused on the use of certain nutrients in a specific age group while the studies on overall 
supplement use were mainly limited to national surveys (Ford & Whiting, 2017). The findings of 
this scoping review suggest that the prevalence of supplement use varied greatly between the 
national surveys and smaller cohort studies. The differences in supplement use observed between 
the national surveys and the smaller cohort studies allude to the importance of smaller cohort 
studies  in specific populations, such as medically-complex older adults, to capture data that is 
likely not apparent in large national surveys (Ford & Whiting, 2017). 
 Studies have investigated older adults’ motivations for vitamin and mineral supplement 
use but a consensus has yet to be achieved (Bailey, Gahche, Miller, Thomas, & Dwyer, 2013; 
Marques-Vidal et al., 2009). Nationally representative data in the United States reported that the 
three most common reasons for dietary supplement use was to “improve overall health”, 
“maintain health”, and “bone health” (Bailey et al., 2013). Despite the previously mentioned 
reasons for dietary supplement use by Bailey et al. (2013), the same study found that more than 
three quarters of participants reported using dietary supplements as a personal choice while less 
than a quarter of participants reported using them secondary to a recommendation from their 
health care provider (Bailey et al., 2013). Dietary supplements are commonly used for a variety 
of reasons, with one reason being that they are available to consumers without a prescription. For 
this reason, health care professionals may be unaware of their patients use of supplements unless 
it is accurately self-reported to the practitioner. Often, people do not think to report the use of 
dietary supplements since they are not a prescription-based product. Many consumers are not 
aware that although supplements can be extremely beneficial to some individuals, they can also 
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put someone at risk if not taken in correct doses or combinations. This phenomenon is likely 
linked to the common consumer misconception that ‘more is better’. In reality, the intake of 
vitamins and minerals has a U-shaped distribution where both minimal and excess intake of a 
particular nutrient can put you at an increased risk for either nutrient deficiency or toxicity (Otten 
et al., 2006).   
 Factors that positively affect supplement consumption include being healthier (Bailey et 
al., 2013) and more educated (Marques-Vidal et al., 2009; Rovira et al., 2013; Vatanparast, 
Adolphe, et al., 2010). Canadian research found that age, sex, household income, education, food 
security, and chronic conditions were all factors independently associated with dietary 
supplement use (Vatanparast, Adolphe, et al., 2010). When compared to other age groups, older 
adults had a greater prevalence of supplement use (Bailey et al., 2013; Marques-Vidal et al., 
2009). Data on sex and age groups show that women over the age of 51 had the highest 
prevalence of supplement use (60%) when compared to other age groups and males 
(Vatanparast, Adolphe, et al., 2010). 
A systematic review on micronutrient intake from diet and supplements in older 
community-dwelling adults concluded that a substantial limitation in the current literature is the 
lack of data on supplement dose and frequency of use (ter Borg et al., 2015). Further, the review 
found that many studies did not distinguish between micronutrient intakes from dietary and 
supplemental form (ter Borg et al., 2015). This information is important as many supplements 
can cause toxicity if taken in large doses, as described below (Otten et al., 2006; Ross et al., 
2011).  
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A recent study in the United States looked at 37 958 adults and reported on national 
trends in their dietary supplement use (Kantor, Rehm, Du, White, & Giovannucci, 2016). Data 
was nationally representative (NHANES) and supplement use data were collected during in-
home interviews that inquired about supplement usage over the past 30 days. For this study, 
supplements encompassed all dietary supplements, not simply vitamin and mineral supplements. 
The main findings of this group included that dietary supplement use increased with age and that 
more women than men reported supplement use. Data from this study indicate that 72% of adults 
65 years of age an older reported the use of at least one dietary supplement. This study found that 
the use of multivitamin/minerals has decreased by approximately 6% since the late 1990’s. 
Interestingly, the data also show that despite the use of vitamin D remaining relatively stable 
over the years, adults are now taking vitamin D as a single-nutrient supplement as opposed to 
getting it in a multivitamin product. Regardless of shifting trends in supplement use, the data 
indicate that overall supplement use in American adults has remained stable since the late 1990’s 
(Kantor et al., 2016).  
The Canadian Community Health Survey (CCHS) is a recurring nationally representative 
survey that includes data collection on nutritional supplements (Statistics Canada, 2013). The 
most recent survey was completed in 2015 and the data became available for analysis in the 
summer of 2017, thus there is currently no published results from the latest survey. The previous 
CCHS was completed in 2004 and provided data on nutritional supplement use (based on the 
previous 30 days) for 35 107 Canadian adults (Guo, Willows, Kuhle, Jhangri, & Veugelers, 
2009; Vatanparast, Adolphe, et al., 2010). Data from this study indicate that the prevalence of 
use was significantly higher in women (46.9%) and that supplement users, especially the older 
adults, were much more likely to reach nutrient adequacy for calcium, when compared to non-
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users (Vatanparast, Adolphe, et al., 2010). Another study that analysed the same survey data but 
focused only on adults found that 40.1% (n = 15 553) reported nutritional supplement use over 
the past 30 days and that for both sexes, supplement use increased with age (Guo et al., 2009). 
Additionally, data indicate that supplement use increased with education and household income, 
and food security; thus, supporting the inverse supplement hypothesis that suggests that those 
who could benefit from supplementation are not the ones using supplements (Guo et al., 2009; 
Vatanparast, Adolphe, et al., 2010).  
Nutrition- and supplement-related data from the 2004 Canadian Community Health 
Survey was also analyzed by another group to gain a better understanding of micronutrient 
inadequacies among the Canadian population and the effect of supplement use on micronutrient 
adequacy (Shakur, Tarasuk, Corey, & O’Connor, 2012). Table 2.2 shows the prevalence of 
micronutrient supplement use by Canadian community-dwelling adults, broken down by sex, age 
group, and nutrient (Shakur et al., 2012). Females over the age of 50 years were more likely 
(60%) to use any vitamin or mineral supplement when compared to males (41%) of the same age 
group. The most used supplements by females over the age of 50 years were calcium (48% use) 
and vitamin D (44% use). In comparison, males of the same age group were most likely to take a 
vitamin C supplement (32% use), followed by a calcium supplement (29% use). Overall, this 
study found that vitamin and mineral supplement use aided Canadians in meeting nutrient 
adequacy but also increased the likelihood of exceeding the UL for one or more nutrients 
(Shakur et al., 2012).  
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Table 2.2: Prevalence of Vitamin Mineral Supplement Use by Adults1 
Consumption of a supplement containing Males >50y (n=4324) Females >50y (n=6175) 
   % (SE)   % (SE) 
Any VM 41 (1) 60 (1) 
MVM2 28 (1) 37 (1) 
Vitamin A 26 (1) 31 (1) 
Vitamin C 32 (1) 38 (1) 
Vitamin D 28 (1) 44 (1) 
Vitamin B6 26 (1) 31 (1) 
Folic Acid 26 (1) 30 (1) 
Vitamin B12 27 (1) 32 (1) 
Thiamin 26 (1) 30 (1) 
Riboflavin 26 (1) 31 (1) 
Niacin 26 (1) 30 (1) 
Calcium 29 (1) 48 (1) 
Phosphorus 18 (1) 18 (1) 
Magnesium 25 (1) 31 (1) 
Iron 20 (1) 24 (1) 
Zinc 23 (1) 28 (1) 
1Values are percentage (SE). VM, vitamin/mineral 
2MVM, multi-vitamin/mineral. MVM = any supplement containing 3 or more vitamins/minerals.  
Adapted from: (Shakur et al., 2012) 
  
2.3 Dietary Reference Intakes 
 Dietary Reference Intakes (DRIs) were created to provide reference values for suggested 
vitamin and mineral intake levels throughout the life cycle for both healthy individuals and 
groups (Otten et al., 2006). The Estimated Average Requirement (EAR) was established as the 
estimated amount of a specific nutrient required to meet the needs of half of a healthy population 
in a specific life stage (Otten et al., 2006). Similarly, the Recommended Dietary Allowance 
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(RDA) was created for each nutrient as a reference amount that will meet the needs of 97-98% of 
healthy individuals within a life stage (Otten et al., 2006). When there is not enough evidence 
available to set an EAR and RDA, an Adequate Intake (AI) level is set based on less evidence 
and assumed to be an adequate intake amount for healthy people (Otten et al., 2006). Lastly, the 
Tolerable Upper-Intake Level (UL) was established as a reference amount where no adverse side 
effects should be observed; although, the risk of experiencing adverse effects increases as intake 
of a nutrient above its UL increases (Otten et al., 2006).  
 As shown in Table 2.3, a UL is established for most nutrients but some nutrients do not 
have enough data available on adverse effects to methodically set a UL (Otten et al., 2006). 
Nevertheless, this lack of evidence on adverse effects does not imply that nutrients with no 
defined UL are safe to consume in high doses as this may still pose risk, especially with chronic 
use (Otten et al., 2006). The UL for a nutrient is set by following a specific method known as the 
Risk Assessment Methodology whereby the literature is critically reviewed and the lowest 
observed adverse effect level (LOAEL) and/or the highest no observed adverse effect level 
(NOAEL) are established (Food and Nutrition Board Institute of Medicine, 1998; Munro, 2006). 
The LOAEL and NOAEL are used in combination with the uncertainty factors to determine the 
UL, which is then set below the LOAEL/NOAEL (Food and Nutrition Board Institute of 
Medicine, 1998; Munro, 2006). Thus, each UL is based on specific criteria, as seen in Table 2.3, 
and assumes chronic intake of the associated nutrient. The evidence used to set each UL is 
nutrient-specific and will be discussed in further detail in Chapter 6 - Discussion.  
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Table 2.3: Criteria Used to Set Tolerable Upper-Intake Levels (ULs) 
Nutrient UL UL for adults was set based on: 
Vitamin A 10,000 IU/day 
retinol 
Liver abnormalities 
Niacin* 35 mg/day   Flushing 
Vitamin B6 100 mg/day Sensory neuropathy 
Folate* 1,000 µg/day  Precipitation or exacerbation of neuropathy in vitamin 
B12-deficient individuals 
Choline 3,500 mg/day Hypotension with cholinergic side effects and fishy body 
odor 
Vitamin C 2,000 mg/day Osmotic diarrhea 
Vitamin D 4,000 IU/day Hypercalcemia 
Vitamin E* 1,000 mg/day Increased tendency to hemorrhage 
Calcium 2,000 mg/day Incidence of kidney stones 
Copper 10,000 µg/day Liver damage 
Fluoride 10 mg/day Skeletal fluorosis 
Iodine 1,100 µg/day Elevated serum thyrotropin concentrations 
Iron 45 mg/day Gastrointestinal distress 
Magnesium* 350 mg/day Diarrhea 
Manganese 11 mg/day Manganese neurotoxicity 
Molybdenum 2,000 µg/day Impaired reproduction and growth in animals 
Phosphorus 4,000 mg/day 
(50-70 y) 
3,000 mg/day 
(70+ y) 
Elevated serum inorganic phosphorus concentration 
Selenium 400 µg/day Selenosis (hair and nail brittleness/loss; gastrointestinal 
disturbance; rash; etc.) 
Zinc 40 mg/day Reduced copper status (reduces red blood cell copper-
zinc superoxide dismutase activity) 
*UL applies only to synthetic and/or supplemental form 
Table adapted from: (Office of Nutrition Policy and Promotion Health Products and Food 
Branch, 2006; Otten et al., 2006; Ross et al., 2011)  
 14 
 
2.4 Safety 
Vitamin and mineral supplement use in a Canadian LTC was examined, and it was found 
that over 70% of participants who were classified as consistent (≥ 3 months) supplement users (n 
= 92) consumed 1-2 dietary supplements per day (Viveky et al., 2012). Overall, 35% of all study 
participants (n = 189) consumed 1-2 supplements daily (Viveky et al., 2012). Data from this 
study also showed that patients who took more than one supplement per day were more likely to 
consume a nutrient from two or more supplement sources (i.e. Vitamin D from a multivitamin 
and from a separate vitamin D supplement) (Viveky et al., 2012). Data from the same study 
showed that only 50% of study participants were consuming a form of supplemental vitamin D 
while Osteoporosis Canada recommends that all adults over the age of 50 should consume a 
vitamin D supplement of 800 – 2000IU/day to ensure adequate intake (Hanley et al., 2010; 
Viveky et al., 2012). Another Canadian study had also investigated the use of supplemental 
vitamin D and found that women between the ages of 51 and 70 had the lowest intake of vitamin 
D from food when compared to other age groups and sex (Vatanparast, Calvo, Green, & 
Whiting, 2010). 
In addition to intake levels of dietary supplements, the content of vitamin and mineral 
supplements is also a potential safety issue. A recent study in the Unites States investigated the 
variability of supplement ingredients (Andrews et al., 2017). Results from this study indicate that 
the mean ingredient content of multivitamin/mineral (MVM) products exceeded the ingredient 
quantities that were reported on the supplement label (Andrews et al., 2017). More specifically, 
data from this study show that 12 nutrients were included in these supplements in amounts at or 
above the RDA and that all nutrients, with the exception of thiamin, were in quantities greater 
than that indicated on the label, when analyzed (Andrews et al., 2017).  
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A nationally representative Canadian study found that adults did not consume nutrients in 
excess of the UL, from diet alone (Shakur et al., 2012). There was no difference between 
supplement users and non-users for all age and sex categories. Data from the same study indicate 
that when a vitamin and/or mineral supplement is consumed, the likelihood of exceeding the UL 
increases. As seen in Table 2.4, ten nutrients were consumed in amounts exceeding the UL by 
supplement users. Approximately half of the males (50%) and females (49%) over the age of 50 
years who consumed supplements exceed the UL for niacin. Women (15%) over the age of 50 
were more likely to have a calcium intake in excess of the UL when compared to men (7%) 
(Shakur et al., 2012).  
Table 2.4: Prevalence of Canadian adults (% (SE)) exceeding the UL from diet + supplement 
Nutrient Males (>50y) Females (>50y) 
Vitamin A < 5 < 5 
Vitamin C < 5 < 5 
Vitamin D < 5 < 5 
Vitamin B6 <5 < 5 
Folic Acid 12 (1) 11 (1) 
Niacin 50 (3) 49 (2) 
Calcium 7 (2) 15 (1) 
Magnesium < 5 10 (1) 
Iron 6 (2) 7 (2) 
Zinc 14 (2) 14 (1) 
Adapted from: (Shakur et al., 2012) 
 
2.4.1 Polypharmacy 
 ‘Polypharmacy’ is a term that is used to describe the use of several (usually 6 or more) 
drugs (Bushardt, Massey, Simpson, Ariail, & Simpson, 2008). A study on older (>75 y) 
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American adults found that 90% of participants who reported dietary supplement use also 
reported the use of at least one prescription medication (Nahin et al., 2009). Similarly, the same 
study reported that over 80% of participants who were prescription drug users reported the use of 
at least one dietary supplement (Nahin et al., 2009). Of the 3,070 participants, over 70% reported 
the simultaneous use of at least one prescription drug and one dietary supplement while over 
30% reported concurrent use of 3 or more drugs and supplements and 10% reported concurrent 
use with 5 or more drugs and dietary supplements (Nahin et al., 2009). Another study advocating 
to change the classification of vitamins from NHPs to drugs highlighted 55 potential vitamin-
drug interactions (Rogovik, Vohra, & Goldman, 2010). This list is not extensive as it does not 
include potential mineral-drug interactions. Although vitamins are not currently classified as 
drugs in Canada, they have both a physiological and pharmacological impact on the body and 
thus have the potential to cause equally adverse effects, especially when taken in combination 
with certain drugs (Rogovik et al., 2010). 
 A Canadian study done in a Medication Assessment Centre (MAC) in Saskatoon, 
Saskatchewan that targets complex patients did a retrospective chart audit of all patients seen 
between March 2014 and July 2015 (Jorgenson et al., 2016). Chart audits were completed on 173 
patient files and data on age, gender, referral source, number of appointments attended, number 
of medications at first appointment, number of medical diagnoses, and number of 
recommendations made by the pharmacist were extracted (Jorgenson et al., 2016). Data from the 
study (n = 173) is summarized in Table 2.5. On average, the patient age was considered elderly 
(64.8 years) but age ranged from 2-93 years. The majority (60.1%, n=104) of patients were 
females and were referred to the MAC by a physician (52.6%, n=91). Data indicate an average 
pill count (including prescription drugs, non-prescription drugs, and natural health products) of 
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13.8 and 6.5 diagnoses per patient, which alludes to the complexity of the patients (Jorgenson et 
al., 2016).  
Table 2.5: Summary of a Study of Patients Receiving Medication Assessments (n = 173) 
Mean age in years (range) 64.8 (2-93) 
Gender 
     Male (%) 
     Female (%) 
 
69 (39.9) 
104 (60.1) 
Number of medical diagnoses 
     Mean (range) 
     Median 
 
6.5 (1-16) 
6 
Number of medications recorded at first appointment* 
     Mean (range) 
     Median    
 
13.8 (1-55) 
13 
Number of recommendations made by pharmacist 
     Mean (range) 
     Median 
 
6.2 (0-22) 
5 
Referral Source 
     Physician (%) 
     Self-referral (%) 
     Nurse Practitioner (%) 
     Other (%) 
 
91 (52.6) 
59 (34.1) 
13 (7.5) 
10 (5.8) 
*Includes prescription drugs, non-prescription drugs, and natural health products  
Adapted from (Jorgenson et al., 2016).  
  
Knowing that older adults have the greatest prevalence of dietary supplement use (Bailey 
et al., 2013; Marques-Vidal et al., 2009; Vatanparast, Adolphe, et al., 2010), and that medication 
usage increases with age (Rotermann, Sanmartin, Hennesey, & Arthur, 2014) it is important to 
have a concrete understanding of the risks involved with concurrent use of dietary supplements 
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and medications. Further research is needed to expand the work done by Jorgenson et al. (2016) 
to investigate concomitant use of supplemental vitamin/minerals and prescription drugs in a 
medically-complex population.  
2.4.2 Drug-Nutrient Interactions 
 Drug-nutrient interactions are difficult to summarize or summate due to the indefinite 
potential of interaction combinations, based on the multitude of factors that are implicated in 
each interaction (Boullata & Hudson, 2012; Santos & Boullata, 2005). Additionally, many 
reported interactions are based off of historic case studies and the actual number of interactions 
that are clinically significant is unclear (Boullata & Hudson, 2012). Broadly, any potential 
interaction can fit into one of five classifications, which are further broken down into the effect 
of a nutrient on a drug or a drug on a nutrient, as seen in Table 2.6 (Santos & Boullata, 2005). 
Tables 2.7 and 2.8 provide a starting point for examining some of the potential drug-nutrient 
interactions likely to be seen in older adults (Nelms, Sucher, Lacey, & Roth, 2011; Otten et al., 
2006; Rogovik et al., 2010; Ross et al., 2011).  
Table 2.6: Santos et al., 2005 Classification of Drug-Nutrient Interactions 
Precipitating Factor Object of 
Interaction 
Potential Consequence 
Altered nutrition status 
Food or food component 
Nutrient or supplement ingredient 
Drug 
Drug 
Drug 
Treatment failure or drug toxicity 
Treatment failure or drug toxicity 
Treatment failure or drug toxicity 
Drug 
Drug 
Nutritional status 
Specific nutrient  
Altered nutritional status 
Altered nutritional status 
 
 As seen in Table 2.6, drug-nutrient interactions can occur when the precipitating factor is 
nutrient related and the object of interaction is a drug or the opposite can occur, where a drug is 
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the precipitating factor and overall nutrition status or a specific nutrient is the object of 
interaction (Santos & Boullata, 2005). Each are equally important but a review of the literature 
indicates limited data on the effect that drugs have on nutrients or overall nutritional status.  
Table 2.7 highlights a few examples of the effects that nutrients can exhibit on drugs while Table 
2.8 provides examples of interactions where drugs exhibit effects on nutrient status (Nelms et al., 
2011; Otten et al., 2006; Rogovik et al., 2010; Ross et al., 2011). Tables 2.7 and 2.8 are not 
meant to be exhaustive lists of potential interactions, but rather illustrate common drug-nutrient 
interactions that are more likely to occur in older adults.  
As seen in Table 2.8, Proton Pump Inhibitor (PPI) drugs interact with several nutrients. 
PPIs are used extensively to treat upper gastrointestinal (GI) disorders such as gastroesophageal 
reflux disease (GERD) (Heidelbaugh, 2013). The extensive use of these drugs is a nutrition-
related concern based on the potential for malabsorption of vitamin C, vitamin B12, calcium, 
iron, and magnesium that is caused by chronic use of this drug. Healthy adults are likely at lower 
risk of experiencing malabsorption of these nutrients while taking PPIs but older adults and 
malnourished individuals are at a much greater risk of experiencing malabsorption; thus, it is 
important to acknowledge the value of understanding the prevalence of these interactions, 
especially when working with older adults who are already at greater risk of malnutrition 
(Denny, 2008; Heidelbaugh, 2013; Kirkpatrick & Tarasuk, 2008). 
From a nutrition standpoint, and due to the lack of literature, it is important to investigate 
the potential for drug-nutrient interactions in terms of nutrient impairment due to drugs. 
Although Table 2.8 is not a complete list of drug-nutrient interactions that can affect nutrient 
status, it is extensive and can be used to gain insight into potential interactions that might be 
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occurring in a group of community-dwelling older adults. This type of data can be used for a 
prospective study that would aid in closing literature gap on this clinically important topic. 
Table 2.7: Potential Drug-Nutrient Interactions 
Nutrient Drug Interaction 
Vitamin E Antiplatelets May increase risk of bleeding 
Vitamin E Anticoagulants May increase risk of bleeding 
Vitamin E Iron May lead to hydroxyl radical production 
Vitamin K Anticoagulants Antagonist 
Folic Acid Methotrexate May reduce efficacy in treatment of cancers and can 
reduce adverse effects when used to treat rheumatoid 
arthritis and psoriasis.  
Folic Acid Proton Pump Inhibitors Antagonist 
Folic Acid H2 Receptor Antagonist Antagonist 
Folic Acid Metformin Antagonist 
Folic Acid Acetaminophen May decrease the elimination rate of the drug 
Vitamin C Aluminum May increase adverse effects (eg. constipation) 
Vitamin C ASA May increase adverse effects (eg. nausea). Attenuates 
ASA-induced gastric damage.  
Vitamin C β-blockers May decrease absorption of the drug. 
Vitamin C Estrogens May increase plasma estrogen levels up to 55%. 
Vitamin C Iron May increase absorption of iron 
Vitamin C Anticoagulants High dosage may reduce response to drug. 
Vitamin C Proton Pump Inhibitors Antagonist  
Vitamin B12 Metformin Antagonist 
Vitamin B12 H2 Receptor Antagonist Antagonist 
Adapted from: (Nelms et al., 2011; Otten et al., 2006; Rogovik et al., 2010; Ross et al., 2011) 
ASA: Acetylsalicylic Acid 
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Table 2.8: Potential Nutrient-Drug Interactions 
Nutrient Drug Interaction 
Vitamin E Laxatives Malabsorption of vitamin E 
Vitamin D 
Vitamin D 
Vitamin D 
Thiazide Diuretics 
Phenobarbital 
Phenytoin 
Hypercalcemia 
Decreases metabolism and half life 
Decreases metabolism and half life 
Vitamin K Laxatives Malabsorption of vitamin K 
Vitamin B6 
Vitamin B6 
Isoniazid 
Levodopa 
Decreases serum vitamin B6 
Decreases serum vitamin B6 
Vitamin B12 Proton Pump Inhibitors Vitamin B12 malabsorption 
Vitamin C Proton Pump Inhibitors Vitamin C malabsorption 
Calcium Corticosteroids Calcium depletion 
Calcium 
Calcium 
Calcium 
Bisphosphonates 
Antihyperlipidemics 
Loop Diuretics 
Calcium depletion 
Calcium depletion 
Calcium depletion 
Calcium H2 Receptor Antagonists Calcium malabsorption 
Calcium Proton Pump Inhibitors Calcium malabsorption 
Calcium Laxatives Calcium malabsorption 
Folate 
Folate 
Folate 
Folate 
Folate 
Methotrexate 
Anticonvulsants 
Pyrimethamine 
Triamterene 
Sulfasalazine 
Folate depletion 
Increased folate metabolism 
Antagonist 
Folate depletion 
Folate depletion 
Potassium Thiazide Diuretics Potassium depletion 
Potassium Loop Diuretics Increased potassium excretion 
Potassium Laxatives Potassium malabsorption 
Potassium NSAIDs Increased potassium excretion 
Magnesium 
Magnesium 
Laxatives 
Proton Pump Inhibitors 
Magnesium malabsorption 
Magnesium malabsorption 
Magnesium Loop & Thiazide Diuretics Magnesium depletion 
Magnesium Antihyperlipidemics Hypermagnesuria 
Chromium Antacids Chromium malabsorption 
Sodium Corticosteroids Sodium retention 
Sodium Loop Diuretics Increased sodium excretion 
Iron H2 Receptor Antagonists Iron malabsorption 
Iron Proton Pump Inhibitors Iron malabsorption 
Iodine Sulfonylureas Impair uptake or release of iodine 
Iodine Lithium Impair uptake or release of iodine 
Adapted from: (Heidelbaugh, 2013; Nelms et al., 2011; Otten et al., 2006; Rogovik et al., 2010; 
Ross et al., 2011) 
NSAID: Nonsteroidal anti-inflammatory drug 
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CHAPTER 3 
SCOPING REVIEW 
This is the accepted manuscript of an article published by Taylor and Francis in Journal of Dietary 
Supplements on August 31st, 2017, available online: http://www.tandfonline.com/ DOI: 
10.1080/19390211.2017.1350247 
 
3.1 Abstract 
Vitamin and mineral supplements can assist a person in meeting recommended intakes 
but excessive use can pose risks. Knowing prevalence of supplement use is the first step toward 
gauging risk-benefit. This scoping review sought to determine the prevalence of vitamin and 
mineral supplement use among community-dwelling Canadian and American adults. Medline 
and Embase were searched using keywords and MeSH headings that encapsulated both vitamin 
and mineral supplements and community-dwelling adults in Canada and the United States. 
Search limits were set for study participants over the age of 18, English language articles, and a 
publication date from the year 2000 to June of 2016. Of the 181 articles originally identified, 30 
were deemed relevant for this scoping review. Eleven studies reported on vitamin and mineral 
supplement use in general, without specifying the prevalence of use for any particular 
supplement(s). Prevalence of general vitamin and mineral supplement use reported in these 
studies ranged from 7-85%. Twenty-two studies reported the prevalence of consumption for 
specific vitamins and minerals; although three of these studies also reported on overall 
supplement use. Calcium and vitamin D were widely reported, with 10 of 22 studies focusing on 
these key nutrients. Multivitamin/mineral supplements were also widely studied with 8 of 22 
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articles reporting their prevalence of consumption. Results from this scoping review indicate that 
data on the quantity and combination of supplement use is lacking in Canada and United States. 
These data are key for identifying intake amounts and combinations that have the potential to 
cause adverse effects. 
3.2 Introduction 
Vitamin and mineral supplements can aid in meeting daily micronutrient requirements; 
but they can also pose a risk for toxicity and/or adverse drug-nutrient interactions if not taken 
appropriately (American Dietetic Association, 2009; Food and Nutrition Board Institute of 
Medicine, 1998). Consumers, who may not be aware of the potential risks associated with 
vitamin and mineral supplement use, may be unsure of how to safely consume these products 
(American Dietetic Association, 2009). Although vitamin and mineral oral supplements are not 
currently classified as drugs (in Canada and the United States), they have both a physiological 
and pharmacological impact on the body similar to that of prescription drugs (Health Canada, 
2011; Rogovik et al., 2010; U.S. Food and Drug Administration, 2008). Based on their 
complexity, the use of vitamin and mineral supplements to increase micronutrient intake, 
especially when taken in combination with over-the-counter and/or prescription medications, can 
be a concern to health care professionals due to the potential for therapeutic failure of 
medications and or supplements (American Dietetic Association, 2009; Rogovik et al., 2010).  
3.3 Background 
Previous research indicates that dietary supplement use, including vitamin and mineral 
supplements, has increased in many nations, especially Canada and the United States (Guo et al., 
2009; Qato et al., 2016). Mainly in response to the rising use of supplements, the Food and 
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Nutrition Board set Tolerable Upper Intake Levels (ULs) to provide guidance for consumers and 
health care professionals when choosing dosage amounts for vitamin and mineral supplements. 
The UL of a vitamin or mineral is defined as “the highest level of daily nutrient intake that is 
likely to pose no risk of adverse health effects to almost all individuals in the general 
population.” (Food and Nutrition Board Institute of Medicine, 1998). Thus, the UL is a reference 
level for tolerable, not recommended, consumption of vitamin and mineral supplements (Food 
and Nutrition Board Institute of Medicine, 1998). Research indicates that although vitamin and 
mineral supplementation can put people at or above the UL; supplementation increases the 
percentage of people who attain adequate nutrient intake (Fulgoni, Keast, Bailey, & Dwyer, 
2011; Shakur et al., 2012). Vitamin and mineral intake at the UL is not necessarily harmful, 
although the risk of adverse effect(s) increases as intake passes the UL (Food and Nutrition 
Board Institute of Medicine, 1998).  
3.4 Description of Subject 
Nationally representative studies are conducted in both Canada and the United States yet 
there remains the need for studies that probe for vitamin and mineral supplement usage in 
specific populations such as clients with complex medical diagnoses. The use and overuse of 
vitamin and mineral supplements has recently been investigated by Dr. Whiting’s group in long-
term care/nursing home residents at risk for polypharmacy (Viveky et al., 2012). We sought, 
however, to determine what studies investigated community-dwelling adults to gain an 
understanding of vitamin/mineral supplement use in this specific group. We conducted this 
scoping review on vitamin and mineral supplement use by community-dwelling adults in Canada 
and the United States to determine prevalence of general and specific use. 
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3.5 Methods 
Using scoping review methodology (Grant & Booth, 2009); two databases (Medline and 
Embase, both via Ovid) were searched for corresponding literature. MeSH headings and 
keywords were used, ensuring that at least one term capturing vitamin and mineral supplements, 
study location, and living arrangements was found in each resulting article. The full list of MeSH 
headings and keywords are found in Table 3.1.  
Table 3.1: List of terms searched in Medline and Embase databases 
Key Variables Medline Embase 
Vitamin and mineral 
supplements Dietary supplements vitamin (exp) 
  Vitamins (exp) mineral (exp) 
  Minerals (exp) trace element (exp) 
  Micronutrients (exp) "dietary supplement*" 
  "multivitamin*" "micronutrient*" 
  "micronutrient intake*" "micronutrient intake*" 
  
((vitamin* OR mineral* OR 
liquid* OR micronutrient* OR 
nutrition* OR food*) AND 
supplement*) 
((vitamin* OR mineral* OR 
liquid* OR micronutrient* OR 
nutrition* OR food*) AND 
supplement*) 
Study location Canada (exp) Canada (exp) 
  United States (exp) United States (exp) 
Living 
Arrangements Independent living independent living 
  "community-dwelling*" "community-dwelling" 
exp = explode   
 
Searches in both databases were limited to the English language, human studies on adults 
(18 years and older), and a publication date from the year 2000 until June of 2016. Search results 
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from both databases were combined and duplicate results were removed. Articles identified 
through reference lists were also included. Titles and abstracts of all articles were reviewed using 
the following inclusion criteria: participants were community-dwelling adults, the study was 
original research (not a review article), and prevalence of vitamin and mineral supplement use 
was reported. Next, the eligible full-text articles were examined using the above inclusion 
criteria. Articles (n = 30) were then placed into two categories: general use of vitamin and 
mineral supplements (Table 3.2) and specific use of vitamin/mineral supplements (Table 3.3). In 
the former category, 8 articles were identified as only providing information on general 
supplement use while 19 articles focused on use of specific supplements. An additional three 
articles were relevant to both of these categories and thus included in each summary table. See 
Figure 1 for details regarding this process and reasons for article exclusion. The following data 
were extracted from all included studies: sample size; location and year of study; a description of 
the research participants, including their age; nutrients of focus; and the percentage of 
participants using vitamin and mineral supplements. 
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Table 3.2: Studies reporting on general supplement use in community-dwelling adults 
(Reference); study location 
Age 
(years) 
Study 
Year 
Participants 
(n) 
% using 
supplements Description of participants 
Canadian Studies      
(Bedford & Barr, 2005); CAN 19-84 
 
1999 
 
1,817 60.2% 
 
Adults from the British Columbia Nutrition 
Survey (BCNS) 
(Guo et al., 2009); CAN 19-50 
51-70 
2004 
2004 
15,553 
4,712 
35.5% 
50.5% 
Canadian Community Health Survey (CCHS) 
 
American Studies      
(Beydoun, Beydoun, Boueiz, 
Shroff, & Zonderman, 2013); 
USA 
20-85 ’05-‘06 1,798 62.6% NHANES participants with complete data sets 
and depressive symptoms 
(Cheung, Wyman, & Halcon, 
2007); USA 
≥65  445 56.2% Randomly selected from Minnesota Driver's 
License/Identification Tape 
(Espino et al., 2000); USA ≥65 ’93-‘94 2,895 6.97% Hispanic Established Population for the 
Epidemiologic Study of the Elderly (EPESE)   
(Mursu, Robien, Harnack, Park, & 
Jacobs, 2011); USA 
55-69 1986 
2004 
38,772 
19,124 
62.7% 
85.1%  
 
Iowa Women’s Health Study 
(Qato et al., 2008); USA 57-84 ’04-‘06 2,976 49.5% National Social life, Health and Aging Project 
(NSHAP) 
(Qato, Manzoor, & Lee, 2015); 
USA 
57-84 2004 2,975 49.4% NSHAP 
(Qato et al., 2016); USA 62-85 ’05-‘06 
’10-‘11 
2,351  
2,206 
51.8%  
63.7% 
NSHAP 
(Raji, Kuo, Snih, Sharaf, & Loera, 
2005); USA 
≥77 ’95-‘98 365 36.2% Oldest participants of the Health of the Public 
Study 
(Weeden & Remig, 2010); USA >80 ’07-‘08 113 85.5% Congregate meal users living in rural 
communities 
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Table 3.3: Studies reporting on specific supplement use in community-dwelling adults 
(Reference); study 
location 
Size of 
Study 
Study 
Year 
Age of 
Participants 
Nutrient(s) 
of focus 
Supplement 
Use (%) Description of Participants 
Studies Targeting Calcium and/or Vitamin D 
(Bakhireva, Barrett-
Connor, Kritz-
Silverstein, & 
Morton, 2004);  
USA 
507 88-'92 
92-'96 
45-92 Calcium 17.6% Cohort of a middle- to upper-class 
Southern California Community 
(Rancho Bernardo) - Men Only 
(Cline & Worley, 
2006);  USA 
990 2003 45+ Calcium 58.4% Surveyed 1700 Minnesota residents – 
Women Only 
(Farley, Cline, & 
Hansen, 2004); USA 
990 2003 45+ Calcium 56.7% Survey sent to 1700 Minnesota 
residents via a mailing list firm - 
Women Only 
(Barake, Weiler, 
Payette, & Gray-
Donald, 2010); CAN 
404 2005-
2006 
68-82 Vitamin D 30.7% subset of Quebec Longitudinal Study 
(NuAge) cohort study; predominantly 
Caucasian men and women  
(Ginter et al., 2013); 
CAN 
224 2012 60-90 Vitamin D 44.8% Cohort of ethnically diverse individuals 
- Square One Older Adult Centre in 
Ontario.  
(Bolland, Grey, 
Gamble, & Reid, 
2011); USA 
36,282 
 
50-79 Calcium and 
Vitamin D 
47.3 – 53.9% Post-menopausal women - Women's 
Health Initiative (WHI) 
(Faulkner et al., 
2006); USA 
9,526 86-'88 
89-'90 
65+ Calcium and 
Vitamin D 
42.8 – 44.9% Study of Osteoporotic Fractures 
(Saquib, von 
Muhlen, Garland, & 
414 1997-
2000 
45-95 Calcium and 
Vitamin D 
9.7 – 21.5% Ranch Bernardo Study - Men Only 
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Barrett-Connor, 
2006); USA 
(Papaioannou et al., 
2008); CAN 
2,187 1996-
2002 
50+ Calcium or 
Vitamin D 
29.8% Canadian Multicentre Osteoporosis 
Study (CaMOS) - Men Only 
Studies Targeting B-Vitamins and Folic Acid 
(Garcia, Day, 
Zanibbi, & 
Zunzunegui, 2008); 
CAN 
281 97-'04 avg 73 (±4.9) 
 
B-Vitamins 
and Folic 
Acid  
27 – 49% Cohort of older adults with and without 
voluntary B-Vitamin supplementation 
(Gougeon et al., 
2016); CAN 
1,368 2003-
2005 
67-84 B-Vitamins 
& Folic Acid  
17.4% Quebec Longitudinal Study (NuAge) 
Studies Targeting Vitamin A 
(Lim, Harnack, 
Lazovich, & Folsom, 
2004); USA 
34,703 86-'97 55-69 Vitamin A 35.4% Iowa Women's Health Study 
(Promislow, 
Goodman-Gruen, 
Slymen, & Barrett-
Connor, 2002); USA 
958 1988-
1992 
55-92 Retinol 45.8% Cohort of a middle- to upper-class 
Southern California Community 
(Rancho Bernardo) 
Studies Targeting Multivitamin/minerals vs. Multiple Sources of Key Micronutrients 
(Nelson, Wengreen, 
Munger, & 
Corcoran, 2009); 
USA 
3,634 1995 65+ MVM 42.7% the Cache County Memory Study 
(Sternberg, 
Chandran, & Sikka, 
2003); USA 
202 2000 avg 80 MVM; Ca; 
Vitamins A, 
B, C, E  
4.9 – 64.7% Convenience sample of patients at the 
University of Chicago primary care 
clinic  
(Nahin et al., 2006); 
USA 
3,072 2000-
2002 
75+ MVM; Ca; 
Vitamins A, 
7.3 – 59.4% Ginkgo Evaluation of Memory Study  
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B, C, D, E; 
Mg; Zn 
(Arcury et al., 2006); 
USA 
701 2002 65+ MVM; Ca; 
Vitamins A, 
B6, B12, C, 
E; Folic 
Acid; Cr; 
Mg; Se; Zn 
0.4 – 34.3% Evaluating Long-Term Diabetes Self-
Management Among Elder Rural 
Adults Study 
(Qato et al., 2016); 
USAa 
2,351 
2,206 
05-'06 
10-'11 
62-85 MVM; Ca; 
Vitamins B, 
C, D, E; Folic 
Acid; Iron; 
Mg; K; 
Niacin; Zn 
1.5 – 34.9% NSHAP 
(Mursu et al., 2011); 
USAa 
38,772 1986 55-69 MVM; 
Vitamins A, 
B6, B 
complex, C, 
D, E; β-
carotene; 
Folic Acid; 
Ca; Cu; Iron; 
Mg; Se; Zn 
0.59 – 44.9% Iowa Women’s Health Study 
Abbreviations: avg, average; BMD, bone mineral density; Ca, calcium; CAM, complementary alternative medicine; Cr, 
chromium; Cu, copper; K, potassium; OTC, over the counter; Mg, magnesium; MVM, multivitamin/mineral; Se, selenium; Zn, 
zinc.  
aArticle also appears in Table 2.  
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Figure 3.1: Scoping review flow chart of searches, inclusions, and exclusions (Moher, Liberati, 
Tetzlaff, Altman, & Group, 2009). 
Records screened 
(n = 139) 
Records after duplicates removed 
(Medline n = 83) 
(Embase n = 53) 
(Other n = 3) 
 
 
 
Records excluded based 
on title and/or abstract 
(n = 73) 
Records identified through 
database searching 
(Medline n = 87) 
(Embase n = 91) 
(Total n = 178) 
Additional records identified 
through other sources 
(n = 3) 
Full-text articles excluded (n = 35) 
Supplement intake not reported (n = 25) 
No full-text published (n = 5) 
Commentary or review paper (n = 2) 
Participants excluded from study if using 
supplements (n = 2) 
Participants not community-dwelling (n = 1) 
Oral liquid nutritional supplement (n = 1) 
Full-text articles assessed 
for eligibility 
(n = 66) 
Studies included in 
scoping review 
(n = 30) 
(General Use n = 8) 
(Specific Use n = 19) 
(Both n = 3) 
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3.6 Results 
Of the 180 articles originally identified, 30 were deemed relevant for this scoping review. 
Several of the selected articles reported data on the same cohort of individuals, as noted in Table 
3.  
3.6.1 General Use of Vitamin and Mineral Supplements  
Eleven studies reported on the general use of vitamin and mineral supplements in 
community-dwelling adults living in Canada or the UnitedStates (Table 2). The majority of these 
studies used large cohorts of participants (n > 1000) (Bedford & Barr, 2005; Beydoun et al., 
2013; Espino et al., 2000; Guo et al., 2009; Mursu et al., 2011; Qato et al., 2008, 2015, 2016) 
while three studies investigated smaller groups of participants (n < 1000) (Cheung et al., 2007; 
Raji et al., 2005; Weeden & Remig, 2010). Both Canada (Guo et al., 2009) and the United States 
(Beydoun et al., 2013; Qato et al., 2008, 2015, 2016) have nationally representative surveys that 
indicate general use of vitamin and mineral supplements among adults was 40.1% (Guo et al., 
2009) and 62.6% (Beydoun et al., 2013) respectively.  
Of the above-mentioned studies, eight investigated supplement use of older adults (>55 
years of age) (Cheung et al., 2007; Espino et al., 2000; Mursu et al., 2011; Qato et al., 2008, 
2015, 2016; Raji et al., 2005; Weeden & Remig, 2010) while only three investigated usage in 
adults starting at 19 years of age (Bedford & Barr, 2005; Beydoun et al., 2013; Guo et al., 2009). 
The studies that included a broader age range of participants had a narrow range of supplement 
users, 40.1% - 62.6% (Bedford & Barr, 2005; Beydoun et al., 2013; Guo et al., 2009), while 
studies investigating older adults reported a wide range, 6.9% - 85.5%, of supplement users 
(Cheung et al., 2007; Espino et al., 2000; Mursu et al., 2011; Qato et al., 2008, 2015, 2016; Raji 
et al., 2005; Weeden & Remig, 2010). 
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The study with the lowest reported use of supplements (6.9%) was conducted in the early 
1990’s on a group of elderly Hispanics in the United States (Espino et al., 2000). In contrast, a 
study done in 2007-2008 on a small group of congregate meal users reported supplement use 
among 85.5% of the participants (Weeden & Remig, 2010).  
3.6.2 Specific Vitamin and Mineral Supplement Use  
Ten of the 22 studies reporting on the use of one, or multiple, specific vitamin and 
mineral supplement(s) focused on the supplementary use of calcium and/or vitamin D 
(Bakhireva et al., 2004; Barake et al., 2010; Bolland et al., 2011; Cline & Worley, 2006; Dam, 
von Muhlen, & Barrett-Connor, 2009; Farley et al., 2004; Faulkner et al., 2006; Ginter et al., 
2013; Papaioannou et al., 2008; Saquib et al., 2006). Three of these articles analyzed data from 
the same cohort, the Rancho Bernardo Study, but investigated different associations such as: 
serum 25-hydroxyvitamin D and bone mineral density; serum vitamin D and physical function; 
and modifiable predictors of bone loss (Bakhireva et al., 2004; Dam et al., 2009; Saquib et al., 
2006). Another two studies used a common cohort of Minnesota residents, with one study 
looking at calcium and resorptive drug use (Farley et al., 2004) while the other study analyzed 
health belief patterns and osteoporosis self-care (Cline & Worley, 2006). Overall, supplemental 
calcium and/or vitamin D use ranged from 9.7% in a small cohort of men (Saquib et al., 2006) to 
58.4% in a cohort of women (Cline & Worley, 2006) and all ten studies recruited participants at 
or over the age of 45 years (Bakhireva et al., 2004; Barake et al., 2010; Bolland et al., 2011; 
Cline & Worley, 2006; Dam et al., 2009; Farley et al., 2004; Faulkner et al., 2006; Ginter et al., 
2013; Papaioannou et al., 2008; Saquib et al., 2006).  
Two studies that focused on the combined use of B-vitamins and folic acid included 
Canadian participants over the age of 65 and looked at the effects of B-vitamin supplementation 
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on biomarkers (Garcia et al., 2008) and the use of supplemental B-vitamins and folic acid on the 
risk of depression (Gougeon et al., 2016). Results show that 17-49% of participants were 
supplementing their B-vitamin and folic acid intake (Garcia et al., 2008; Gougeon et al., 2016).  
Supplemental vitamin A was the focus of two studies investigating the effect of excess 
vitamin A on bone health in older adults (>55 years) (Lim et al., 2004; Promislow et al., 2002). 
One study examined data from the Rancho Bernardo Heart and Chronic Disease study that used 
a population-based cohort in California that was comprised mainly of elderly, white, middle- and 
upper-class residents (Promislow et al., 2002). This data set was also analyzed in three other 
studies used in this review (Bakhireva et al., 2004; Dam et al., 2009; Saquib et al., 2006). 
Of eight American studies investigating the use of multivitamins/minerals and multiple 
sources of key micronutrients in adults over 55 years of age, two studies analyzed data from the 
National Social Life, Health, and Aging Project (NSHAP), a nationally representative 
longitudinal study of community-dwelling American adults (Arcury et al., 2006; Mursu et al., 
2011; Nahin et al., 2006; Qato et al., 2008, 2016; Sternberg et al., 2003). One looked at the 
prevalence and patterns of medication use as well as potential drug-drug interactions (Qato et al., 
2008) while the other focused on the changes in prescription, over-the-counter, and dietary 
supplement usage over a period of five years (Qato et al., 2016). Three studies reported on 
general supplement use (Table 2) and specific usage (Mursu et al., 2011; Qato et al., 2008, 
2016). Seven studies found that multivitamin/mineral use had the highest prevalence of use 
compared to all other supplement types, ranging from 28% - 64.7% (Qato et al., 2008; Sternberg 
et al., 2003). The study targeting post-menopausal women was the only study where the highest 
prevalence of supplement use was calcium, with 44.9% of participants reporting usage (Mursu et 
al., 2011). Note that this study was completed in the 80’s while the remainder of the studies 
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collected data in the 2000’s. With the exception of niacin (Qato et al., 2008), the lowest 
prevalence of vitamin and mineral supplement use was of minerals, ranging from 0.4% - 7.3% of 
participants reporting supplemental use of chromium and magnesium, respectively (Arcury et al., 
2006; Nahin et al., 2006; Qato et al., 2008, 2016; Sternberg et al., 2003).  
3.7 Discussion 
 The aim of this scoping review was to summarize the existing literature on vitamin and 
mineral supplement use in community-dwelling Canadian and American adults and to identify 
any gaps in the literature for this specific population. We compared the prevalence of general 
vitamin and mineral supplement use with that of specific vitamin and mineral supplements. The 
majority (n = 22) of the studies focused on specific vitamin and mineral supplements, 11 studies 
provided data on the use of any, non-specified, vitamin or mineral supplement. Prevalence of 
supplement use ranged widely in both instances with a higher prevalence (85%) reported for 
general supplement use, compared to 64% use of a specific supplement (Mursu et al., 2011; 
Sternberg et al., 2003). It is not surprising that studies reporting on the general use of vitamin and 
mineral supplements found a higher prevalence of use among study participants as these studies 
inquired about use of all dietary supplements while studies investigating specific use only 
reported the prevalence of use for the vitamin and mineral supplement(s) for which they were 
interested.  
Although our search limit was set at all adults 18 years and older for all study 
participants, by selecting for “community-dwelling” all but three studies (the national surveys) 
focused on supplement use in older adults. The focus on older adults is justified as it is known 
that certain nutrient requirements increase or decrease with age (Otten et al., 2006; Ross et al., 
2011). Men and women over the age of 50 require an increased amount of vitamin B6 and are 
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recommended to take a vitamin B12 supplement as their ability to absorb food-bound vitamin 
B12 decreases with age (Otten et al., 2006). Women over the age of 50 and men over the age of 
70 are recommended to increase their calcium consumption to maintain adequate levels of intake 
(Ross et al., 2011). The suggested intake levels for vitamin D also increases for both sexes after 
the age of 70 (Ross et al., 2011). After the age of 50, iron requirements for women decrease 
(Otten et al., 2006). Research on older adults shows that the prevalence of nutrient inadequacy 
from diet alone is very high for vitamin D and calcium but that the prevalence of inadequacy is 
significantly reduced when a supplement is included daily (Shakur et al., 2012). Similar findings 
were also reported for vitamin B6 (Shakur et al., 2012). The risk of vitamin/mineral 
overconsumption is illustrated by a study that investigated supplement use and mortality in older 
women and found that high doses of supplemental iron was associated with an increased risk of 
mortality; whereas, supplemental calcium was inversely related to mortality (Mursu et al., 2011). 
Trends in vitamin and mineral supplement use are apparent in Table 3. For example, all 
studies on calcium that were included in this scoping review were conducted from the 1980’s to 
2003 while concerns about vitamin A became apparent in the 1980’s and 1990’s, leading to 
publications on the implications of this vitamin. Although calcium was already known to have 
associations with bone health, vitamin A also became a relevant player in bone health, leading to 
an increase of studies relating to this nutrient. A critical review paper appraised a study on diet 
and bone health in Europe that found a negative relationship between excess retinol intake and 
bone mineral density and a positive relationship between excess retinol intake and the risk of hip 
fracture (Melhus et al., 1998; Whiting & Lemke, 1999).  
Multivitamins/minerals were more commonly consumed when compared to individual 
nutrient supplements. Recent nationally representative data for the United States indicates and 
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increase in vitamin and mineral supplement use from 51.8% in 2005-2006 to 63.7% in 2010-
2011 (Qato et al., 2016). Nationally representative survey data in Canada indicated that 40% of 
Canadian adults acknowledge use of one, or multiple, vitamin and mineral supplements in 2004 
(Guo et al., 2009). The same Canadian survey was repeated in 2015 but results are yet to be 
disseminated. The second part of the Iowa Women’s Study, conducted in 2004, also reported a 
high prevalence of supplement use, with 85.1% of the over 19,000 participants reporting dietary 
supplement use, a jump from 62.7% that was reported in 1986 (Mursu et al., 2011). A small 
Canadian study investigated the use of B-vitamins over time but it was unclear how the 
participants were assessed for B-vitamin use (Garcia et al., 2008).  
 From the 30 studies of community-dwelling adults identified as relevant for this scoping 
review, 23 of them were conducted in the United-States while seven were conducted in Canada. 
Of the seven articles reporting on Canadian data, two used the same data set, The Quebec 
Longitudinal Study, one article analyzed nationally representative data from the Canadian 
Community Health Survey, and the remainder investigated smaller cohorts of participants from 
different provinces. The American studies focused both on large surveys as well as specific 
groups of individuals such as the elderly (≥ 77 years) (Raji et al., 2005) or women (Mursu et al., 
2011). Nationally representative surveys provide a population overview but studies on targeted 
cohorts provide an in-depth view that is not likely to be captured at a national level. For example, 
over 85% of a small cohort of American congregate meal users over the age of 80 were dietary 
supplement users (Weeden & Remig, 2010) while only 6.9% of participants in a study of elderly 
Hispanic Americans reported use (Espino et al., 2000). Overall, few Canadian studies 
investigated dietary supplement use of specific vitamins/minerals in small cohorts and no 
Canadian studies looked at overall vitamin and mineral supplement use in these types of groups. 
 38 
 
The two Canadian studies that focused on adults starting at the age of 19 were a large provincial 
and a national survey (Bedford & Barr, 2005; Guo et al., 2009). Data from the national survey 
showed that older adults, 51-70 years, had higher supplement use (50.5%) compared to younger 
adults (35.5%), indicating greater prevalence of use in older adults (Guo et al., 2009). Unlike 
North America, dietary surveys in Europe indicate a much lower prevalence of vitamin and 
mineral supplement use, varying between 9.3-26% (Marques-Vidal et al., 2009; Rovira et al., 
2013). This scoping review demonstrates that Canada lacks published studies on specified 
groups of community-dwelling adults.  
3.8 Limitations 
A limitation of this scoping review is that many of the research articles did not define 
“supplement use” in terms of frequency. Thus, our focus could only be on prevalence of use. The 
majority of the studies relied on self-reported data as opposed to reviewing supplement bottles 
and packaging as a part of the data collection; nonetheless intervention studies were not included 
as they would not illustrate voluntary use of supplements. Lastly, the extent to which participants 
were taking one, or more, vitamin and/or mineral supplement(s) was unclear as ‘pill counts’ were 
not typically reported. Thus, due to these limitations, health outcomes of vitamin and mineral 
supplement use could not be addressed.  
3.9 Implications for Practice 
 This scoping review illustrates the need for further investigation into the risks and 
benefits of vitamin and mineral supplement use by community-dwelling adults. Supplement use 
is warranted in many situations while it can also pose risk if not taken appropriately. Health care 
professionals should inquire about their patient’s use of vitamin and mineral supplements and 
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assist them in understanding appropriate use of supplements to decrease the risk of adverse 
effects.  
3.10 Conclusion 
A total of 30 Canadian and American original research articles on the general and 
specific use of vitamin and mineral supplements were analyzed for this scoping review. The 
majority of the research pertaining to general use of vitamin and mineral supplements was 
conducted in the United States and used large, nationally representative cohorts of participants. 
Interestingly, all research articles that focused on specific supplements investigated the effect 
that the use (or not) of these supplements had on another variable. Thus, none of the studies used 
in this scoping review simply looked at what type, the quantity, and in what combination people 
are consuming vitamin and mineral supplements. This information is important for identifying 
possibly adverse combinations or amounts of supplement use. Future research should aim to fill 
this identified gap in literature to provide a better understanding of the types of vitamin and 
mineral supplements being used by differing cohorts of individuals. 
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CHAPTER 4 
METHODOLOGY 
4.1 Study Purpose 
The purpose of this research project was to assess vitamin and mineral supplement use in 
older adults with complex medication use by: identifying use and overuse of vitamin and mineral 
supplements; determining the extent that people were consuming supplemental nutrients from 
multiple sources; and investigating the potential for adverse drug-nutrient interactions stemming 
from presence or absence of supplement use.  
4.2 Research Design 
The research design for this project was a retrospective chart review of patients who had 
sought the services of the Medication Assessment Centre (MAC) at the University of 
Saskatchewan since its inception in January of 2014 up to January 19th, 2017. The primary 
outcome was to characterize the vitamin and mineral supplement use by MAC patients. 
Secondary outcomes included identifying potential drug-nutrient interactions that stemmed from 
supplement use.  
The MAC opened in 2011 as a patient care clinic in the College of Pharmacy and 
Nutrition at the University of Saskatchewan. As a faculty-run patient care clinic it offers 
complex patients the opportunity, at no personal cost, to have their prescription drugs, over-the-
counter (OTC) products, and dietary supplements assessed by a pharmacist, with assistance from 
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pharmacy students. The MAC accepts patients of all ages through self-referral or by referral of a 
health care professional (Jorgenson et al., 2016; University of Saskatchewan, n.d.).  
4.3 Research Plan 
 This research proposal was approved by the student researcher’s advisory committee and 
data extraction and analysis has been completed. The student researcher coordinated with the 
director of the MAC to gain access to the electronic chart database. A data extraction form was 
created by the student researcher (Appendix A). Each patient chart was assigned a non-
identifying code that was linked to their chart number. Demographic data such as gender, age, 
and postal code was collected. Chronic diseases or health conditions that were noted in the chart 
were also extracted. Lastly, the product name and reported dosage and frequency of prescription 
medications, dietary supplements, and OTC products were extracted from each chart.  
 Statistical analysis of the data was performed using IBM SPSS Statistics software. 
Standard formulations from brands such as Centrum and Jamieson were used when specific 
brand names of supplements were not available in the chart, as shown in Table 4.1. For example, 
if a supplement was listed in the patient chart as “MVM” then the formulation for Centrum 
Silver was used to calculate the vitamin and mineral intake from this product. Centrum Silver 
was chosen as there are generic brands (ex. London Drugs) available that mimic the formulation 
of Centrum Silver. The total amount of each supplemental nutrient was summated and compared 
to the respective UL. The number of supplements providing a specific nutrient was also recorded 
(i.e. if a patient reported taking a vitamin D supplement and a multivitamin containing vitamin 
D). Possible relationships were analyzed between product and demographic data.  
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Table 4.1: Brand name formulations used for data when specific brand not available in chart 
Information in Patient Chart Brand Formulation used for Data 
MVM Centrum Select Essentials Adults 50+ 
50+ MV Centrum Select Essentials Adults 50+ 
Women’s MV Centrum Women 
B Complex Jamieson B50 Complex 
B50 Complex Jamieson B 50 Complex 
B100 Complex Jamieson B100 Complex 
Vitamin B 100mg Jamieson B100 Complex 
Ca/Mg Jamieson Calcium Magnesium 
Ca/Mg/Zn Jamieson Calcium Magnesium Zinc 
Ca/Mg/D3 Jamieson Calcium Magnesium + Vitamin D3 
  
A list of potential nutrient-drug interactions was modified from four sources and can be 
found in section 2.4.2 of the literature review. This was not an exhaustive list but rather a list of 
interactions with a high likelihood of occurrence in the study population, derived as follows. The 
primary MAC pharmacist reviewed an extensive list of drug-nutrient interactions (Heidelbaugh, 
2013; Nelms, Sucher, Lacey, & Roth, 2011; Office of Nutrition Policy and Promotion Health 
Products and Food Branch, 2006; Rogovik, Vohra, & Goldman, 2010; Ross, Taylor, Yaktine, & 
Del Valle, 2011) and noted the drugs that he never encountered, rarely encountered, and often 
encountered with MAC patients over the previous six years. The drugs that he often encountered 
were listed with possible interactions to common vitamin and minerals. 
As discussed in section 2.4.2 of the literature review, drug-nutrient interactions are 
difficult to summate due to the multitude of possible combinations and factors that affect the 
interactions. Likely, this is a reason that much of the literature on drug-nutrient interactions is 
displayed in the form of case studies. For this study, the data extraction form (Appendix A) and 
the list of interactions (Table 2.8) were used to link potential interactions and highlight their 
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occurrences by means of case studies. The case studies were chosen based on the top four drug 
users in our data set as they were assumed to be the most likely to experience the effect of drugs 
on nutrient status.     
4.4 Sample Selection 
 The inclusion criteria for this retrospective chart review were all MAC clients who were 
50 years of age or older at the time of their initial assessment and had at least one drug or dietary 
supplement recorded in their chart. MAC client interactions with the pharmacist are often audio 
and video recorded for teaching purposes and all MAC clients are offered the opportunity to 
decline video and audio recording of their appointment(s). As a safeguard, any client who 
declined video and audio recording was assumed to have declined that their data be used for 
research purposes, and thus their chart information was not extracted as a part of data collection 
for this study. A total of 286 patient charts were reviewed.  
4.5 Statistical Analysis 
As seen in the Data Extraction Form (Appendix A), gender, age, postal code, reported 
chronic disease and health issues, prescribed drugs, dietary supplements, and OTCs were 
extracted from patient charts for those who were over the age of 50 at the time of their initial 
appointment. SPSS software was used to statistically analyze the data. Descriptive statistics such 
as prevalence, frequencies, and means were calculated. Associations such as Chi-Square tests for 
independence were also used to analyze relationships. 
For this research project, dietary supplements were defined as any vitamin and/or 
mineral-containing supplement. Patients of the MAC were instructed to bring all medications, 
OTCs, and supplement bottles to their first appointment for the pharmacist to review and record 
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name, dosage, and frequency of each drug and/or supplement. Only oral prescription and OTC 
products were tabulated for the purpose of this study; thus, drugs and OTC products that were 
taken via injection, topical application, inhalation, etc. were not included as these formulations 
rarely involve vitamins and/or minerals. Pill count was defined as the total number of 
prescription medications, dietary supplements, and OTC drugs, with the acknowledgement that 
the patient may consume more than one tablet per day to meet their prescribed, recommended, or 
chosen dosage. ‘Overuse’ of vitamin and mineral supplements was determined by summating the 
total amount of each nutrient consumed and comparing the total intake to the respective UL. As 
discussed in the literature review, some nutrients do not have a set UL thus these nutrients were 
not considered when discussing ‘overuse’ as there was no comparative measure available. For 
the nutrients with a defined UL, a patient was considered to have ‘overused’ a supplement if 
their intake was equal to or greater than the defined UL. Since dietary intake was not assessed, it 
in important to include those who consumed supplemental nutrients at the UL because when 
food is taken into consideration, it is likely that they would surpass the ULs for nutrients where 
food contributes to nutrient intake levels. “Non-vitamin/mineral supplements” included dietary 
supplements that did not contain any vitamins or minerals.   
4.6 Ethics Approval 
This study was approved by the University of Saskatchewan Biomedical Research Ethics 
Board on July 20th, 2016 and re-approved on June 29th, 2017 (Bio 16-169). Formal patient 
consent was not required as this was a retrospective study and the researcher did not extract any 
identifiable information as a part of the data collection process. 
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CHAPTER 5 
RESULTS 
5.1 Demographic Data 
 A total of 286 patient charts were available for review but 48 charts were excluded due to 
age (< 50 y), 8 charts were excluded because the patient was never seen for their initial 
assessment at the MAC (and no medications were recorded in their chart), and 1 chart was 
excluded because there were no medications listed on file at the time of data extraction. Thus, 
229 charts met all inclusion criteria. Subject age at the time of initial assessment ranged from 50 
to 93 years, with a mean age of 68.9 (median: 69) years. Females represented 57.2% of the 
sample (n = 131). Health conditions, tabulated based on those reported by subjects and recorded 
in the medical chart, numbered from 1 to 16 per person, with an average of 4.8 (median: 5.0) 
reported health conditions per person, as seen in Table 5.1.  
Table 5.1: Summary of Demographics and Product Usage 
 Minimum Maximum Mean Median 
Age (y) 50 93 68.9 69 
Reported Health Conditions 1 16 4.8 5 
Prescription Drugs + OTC’s 0 18 6.5 6 
Vitamin and Mineral Supplements 0 19 2.4 2 
NVM Supplements 0 23 0.9 0 
Total Product Count 1 45 9.8 9 
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 Prescription drugs and medications that can be bought over-the-counter (OTC) were 
tabulated as one category because it was often unclear in the chart whether the OTC product was 
prescribed by a health care professional or taken based on personal preference. Prescription drug 
and OTC use ranged up to 18 products per person, with an average product count of 6.5 (median: 
6.0) per person. Pill count was not done but would be equal or greater than the product count.   
 In the MAC population, vitamin and mineral supplement use ranged from no use (0) to 
the use of 19 various products. The mean use of vitamin and mineral supplements was 2.4 
(median: 2.0) products per person. The use of non-vitamin/mineral (NVM) supplement products 
was less, overall, with a mean usage of 0.9 (median: 0) products per person but the range was 
higher than that of the vitamin and mineral supplement usage, with one subject reporting use of 
23 NVM supplement products.  
 Prescription drugs, OTC products, vitamin and mineral supplements, and NVM 
supplements were summated to give a total product count. All subjects had a product count of at 
least 1 and some ranged to as high as 45 products. The average product count was 9.8 products 
per person with a median of 9. Again, this does not encompass the total number of pills taken 
daily.  
5.2 Use of Vitamin and Mineral Supplements 
 Data indicate that 76.9% (n = 176) of patients aged 50+ years reported using one or more 
vitamin and/or mineral supplement(s) daily (Table 5.2). Vitamin D was the supplement taken the 
most frequently, with 78% of supplement users reporting use. A multivitamin/mineral product 
was the next most reported supplement, with 54% of supplement users and 41% of patients 
reporting daily consumption. The third most reported supplement was vitamin C, with 29% of 
 47 
 
supplement users reporting daily use. As seen in Table 5.3, vitamin and mineral supplement use 
was independent (p > 0.05) of age both when ages were grouped by decades or when looked at 
as subjects who were 50-69 years old (n = 118) and those 70+ years of age (n = 111). Based on 
the percentage of supplement users in each age group, there was a slight but not significant 
increase in supplement use as age increased. Similarly, vitamin and mineral supplement use was 
independent of sex (p > 0.05) with 77.5% (n = 76/98) of males and 76.3% of females (n = 
100/131) reporting daily usage. 
Table 5.2: Vitamin and/or mineral supplement (VMS) use by different population variables 
  VMS Use 
 No. of Subjects No. of Subjects % 
Overall  229 176 76.9 
Age Group, years    
50-59 
60-69 
70-79 
80-89 
90+ 
56 
62 
69 
38 
4 
38 
47 
57 
30 
4 
67.8 
75.8 
82.6 
78.9 
100 
Sex    
Male 
Female 
98 
131 
76 
100 
77.5 
76.3 
Self-Reported Health Conditions    
≤ 6 
≥ 7 
182 
47 
135 
41 
74.2 
87.2 
Medication/OTC Use    
≤ 7 
≥ 8 
146 
83 
108 
68 
74.0 
81.9 
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Vitamin and mineral supplement use and the number of self-reported health conditions 
are also independent of one another (p > 0.05). Table 5.2 shows that the percentage of 
supplement users increases for those who reported seven or more health conditions (87.2%), 
when compared to those who reported 6 or less health conditions (74.2%). Similarly, reported 
use of vitamin and mineral supplements was independent of prescription drug and OTC use (p > 
0.05) but Table 5.2 shows that the percentage of patients using vitamin and mineral supplements 
is greater in those who take eight or more prescription drugs and OTC products (81.9%) when 
compared to those who take seven or less (73.9%).  
Table 5.3: Associations between supplement use and patient characteristics 
Variable 1 (Y/N) Variable 2 P-Value 
VM Supplement Use Age (by decades) 0.234 
VM Supplement Use Age (<70/70+) 0.074 
VM Supplement Use Sex (M/F) 0.829 
VM Supplement Use Health Conditions (<7/7+) 0.058 
VM Supplement Use Drug + OTC (<8/8+) 0.170 
≥ 400 IU Vitamin D Age (<70/70+) 0.010 
≥ 400 IU Vitamin D Sex (M/F) 0.226 
≥ 400 IU Vitamin D Nutrients from Multiple Sources (Y/N) <0.001 
Nutrients from Multiple Sources Nutrient intake at or above UL (Y/N) <0.001 
 
5.2.1 Supplemental Vitamin D 
Daily use of supplemental vitamin D (≥ 400 IU) was reported by 64.6% (n = 148) of 
patients. The percentage of subjects taking supplemental vitamin D at or above 400 IU per day 
increased with age, with 56.8% of subjects between the ages of 50 and 69 reporting daily use 
while 72.9% of those patients 70 years and older reported taking 400 IU or more of supplemental 
vitamin D daily (Table 5.4). Daily use of supplemental vitamin D (≥ 400 IU) was associated with 
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age (p 0.01 < 0.05) when comparing patients aged 50-69 years with those 70+ years of age. 
Females were more likely (67.9%; n = 89/131) to take supplemental vitamin D at or above the 
recommended daily dose (400 IU) compared to men (60.2%; n = 59/98). The association 
between supplemental vitamin D use of 400 IU/day or more and sex was not statistically 
significant (p > 0.05). 
Table 5.4: Supplemental vitamin D use by population variables 
   ≥ 400 IU Daily Supplemental Vitamin D 
  No. of Subjects No. of Subjects % 
Overall  229 148 64.6 
Age     
 50-69 118 67 56.8 
 70+ 111 81 72.9 
Sex     
 Male 98 59 60.2 
 Female 131 89 67.9 
 
5.3 Overuse of vitamin and mineral supplements  
Data from this study indicate that 63 of the 229 patients (27.5%) exceeded the UL for at 
least one nutrient, from supplements alone. Data also indicate that 6.5% (n = 15) of patients in 
this study consumed supplemental nutrient(s) in amounts equal to the UL. Dietary intake data 
was not available for this study but it is highly probable that if dietary intake were considered, 
many of these patients would have exceeded the UL for nutrients where food intake contributes 
to the UL, suggesting that this was an underestimation of the risk. In total, 70 patients (30.6%) in 
this study consumed supplemental nutrients at or above the UL. Of reported supplement users (n 
= 176), 39.8% reported overuse of supplements. As seen in Table 5.5, since some patients 
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consumed more than one nutrient at or above the UL, the total number of patients that overused 
supplements is not a direct summation of those who consumed nutrients at the UL plus those 
who consumed nutrients above the UL.  
Table 5.5: Overuse* of supplemental nutrients by reported supplement users (n = 176) 
Nutrient At UL 
 
Over UL 
 
Total Overuse*  UL† Average Intake 
at or over UL 
 N (%) N (%) N (%) mg/day mg/day 
Niacin^ 0 (0) 26 (14.7) 26 (14.7) 35  155  
Magnesium^ 1 (0.6) 22 (12.5) 23 (13.1) 350  586  
Iron 0 (0) 14 (7.9) 14 (7.9) 45  135  
Vitamin D 2 (1.1) 11 (6.2) 13 (7.4) 4000 IU/day 5223 IU/day 
Folate^ 3 (1.7) 9 (5.1) 12 (6.8) 1 2.5 
Zinc 2 (1.1) 10 (5.7) 12 (6.8) 40  60  
Vitamin B6 6 (3.4) 5 (2.8) 11 (6.2) 100  139  
Vitamin C 1 (0.6) 6 (3.4) 7 (3.9) 2000  3070  
Calcium 1 (0.6) 1 (0.6) 2 (1.1) 2000  2100  
Manganese 0 (0) 1 (0.6) 1 (0.6) 11  30  
*Overuse defined as consumption at and over UL 
^UL only applies to synthetic form 
†(Otten, Pitzi Hellwig, & Meyers, 2006; Ross et al., 2011) 
  
 
Data from this study indicate that niacin (also called vitamin B3) was taken in excess of 
the UL most frequently (26 times) in comparison to the other micronutrients.  Of those who 
exceeded the UL for niacin, 84.6 % were taking a B Complex vitamin product. No patients 
reported supplemental intake of niacin equal to the UL of 35 mg/day. Supplemental magnesium 
was taken in excess of the UL by 22 patients and in an amount equal to the UL by one patient. 
Iron was taken in excess of the UL by 14 patients and no supplement users reported intake equal 
to the UL. Of the 148 patients who took a vitamin D supplement at or above the recommended 
amount for this age group (400 IU/day), only 11 patients (7.4%) took it in an amount above the 
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UL and 2 patients reported supplemental vitamin D intake of 4000 IU/day (UL). As seen in 
Table 5.5, other nutrients were also taken in amounts equal to or exceeding the UL, from 
supplements alone, include folate (12 patients), zinc (12 patients), vitamin B6 (11 patients), 
vitamin C (7 patients), calcium (2 patients), and manganese (1 patient). Nutrients with a defined 
UL that was not exceeded include: vitamin A, vitamin E, choline, copper, fluoride, iodine, 
molybdenum, nickel, phosphorus, selenium, vanadium, sodium, chloride, and boron.  
The average vitamin and mineral supplement intake of reported supplement users who 
consumed nutrients at or above the UL is compared to the UL for each nutrient in Table 5.5. The 
average intake of supplemental niacin, among VMS users who reported an intake of 
supplemental niacin above the UL, was 155 mg/day which is 4.4 times the UL for this nutrient 
(35 mg/day). Of the 14 patients who consumed supplemental iron in excess of the UL (45 
mg/day), the average intake was 135 mg/day which is three times the UL. Folate was consumed 
in amounts equal to the UL by 3 patients while 9 other patients consumed folate in amounts 
greater than the UL. The average folate intake of these patients was 2570 µg/day, more than 2.5 
times the UL of 1000 µg/day. Table 5.5 shows the extent to which other nutrients were 
consumed in excess of the UL. 
5.4 Vitamin and Mineral Supplement Use from Multiple Sources 
Results from this study show that 76 of the 229 subjects (33.2%) or 76 of the 176 
supplement users (43.2%) reported taking one or more supplemental nutrients from multiple 
sources. For example, taking a multivitamin containing niacin and taking a B complex that also 
contains niacin. Up to 16 supplemental nutrients were taken from more than one source by 
patients. On average, those who reported nutrient consumption from more than one source did so 
for 3.1 nutrients (median: 2.0).  
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Of the 76 subjects who took supplemental nutrients from multiple sources, 53.9% (n = 
41) took supplemental nutrient(s) in amounts equal to or greater than the UL. As seen in Table 
3.3, nutrient intake from multiple supplemental sources was significantly associated (p < 0.001 < 
0.05) with intake of supplemental nutrients in amounts at or above the UL. Similarly, of the 76 
patients who took supplemental nutrients from multiple sources, 86.8% (n = 66) reported taking 
supplemental vitamin D from 2 or more sources. Additionally, supplemental vitamin D intake at 
or above the recommended intake level of 400 IU per day was significantly associated (p < 0.001 
< 0.05) with reported intake of nutrients from multiple sources. 
5.5 Potential Drug-Nutrient Interactions 
 For the purpose of this study, drug-nutrient interactions were investigated in the context 
of how a drug affects nutrient status. Due to the retrospective nature of this study, it is impossible 
to know whether the patient exhibited symptoms of the potential drug-nutrient interactions. As 
discussed in the literature review, the multitude of factors affecting drug-nutrient interactions 
makes for an extensive list of potential interactions thus, drug-nutrient interactions were 
investigated through four case studies, as shown in Tables 5.7-5.10. The case charts selected for 
case study were chosen based on the top oral drug users in the population. A summary of likely 
drug-nutrient interactions from the 4 case studies is shown in Table 5.6.  
Case 1 (Table 5.7) was a 53-year-old male who reported taking 18 drugs and no 
nutritional supplements. Of the 18 drugs being taken by this patient, 3 of the drugs had the 
potential to interact with nutrients. Firstly, the docusate sodium (a laxative) could potentially 
have led to malabsorption of vitamin E, vitamin K, calcium, potassium, and magnesium. The 
patient was also taking rabeprazole sodium (a PPI), with had the potential to cause malabsorption 
of vitamin C, vitamin B12, calcium, iron, and magnesium. The last drug that this patient was 
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taking that had the potential to interact with nutrient status was ranitidine (an antacid) that could 
cause malabsorption of chromium. Since this patient was not taking any supplemental nutrients, 
there was a greater potential for heightened risk of long term negative impacts on health status 
from chronic malabsorption due to the laxative, PPI, and antacid. 
Table 5.6: Summary of potential drug-nutrient interactions from 4 case studies  
Drug Nutrient Interaction 
Bisphosphonate Calcium Calcium depletion 
NSAID Potassium Risk for hyperkalemia 
H2 Receptor 
Antagonist 
Calcium 
Iron 
Chromium 
Risk for nutrient malabsorption 
Laxative 
 
Vitamin E 
Vitamin K 
Calcium 
Potassium 
Magnesium 
Risk for nutrient malabsorption 
Loop Diuretic  Calcium 
Potassium 
Magnesium 
Risk for nutrient depletion 
Thiazide Diuretic Potassium 
Magnesium 
Risk for nutrient depletion 
Thiazide Diuretic Calcium Stimulate calcium reabsorption 
Anticonvulsant Folate Risk for nutrient depletion 
Proton Pump 
Inhibitor (PPI) 
Vitamin C 
Vitamin B12 
Calcium 
Iron 
Magnesium 
Risk for nutrient malabsorption 
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Table 5.7: Case #1 of potential drug-nutrient interactions   
Sex Oral 
drugs 
Supp. 
Use 
Drug Nutrient Interaction Effect of 
Supplement Use 
M 18 0 Docusate Na+ 
(Laxative) 
Vitamin E 
Vitamin K 
Calcium 
Potassium 
Magnesium 
Malabsorption 
 
 
 
 
No nutrient 
supplementation by 
patient. 
   Rabeprazole 
Na+ (PPI) 
 
Vitamin C 
Vitamin B12 
Calcium 
Iron 
Magnesium 
Risk for 
nutrient 
malabsorption. 
No nutrient 
supplementation by 
patient. 
 
   Ranitidine 
(H2 Receptor 
Antagonist) 
Chromium Risk for 
malabsorption. 
No nutrient 
supplementation by 
patient. 
 
Case 2 (Table 5.8) was a 60-year-old female with 18 oral drugs listed in her chart and 10 
dietary supplements (vitamin/mineral and non-vitamin/mineral). The daily use of esomeprazole 
(a proton pump inhibitor (PPI)) may have put the patient at risk for malabsorption of vitamin C, 
B12, calcium, iron, and magnesium. This patient was on 6 supplements containing vitamins and 
minerals, thus was receiving supplemental doses of the potentially affected nutrients on a daily 
basis. The patient was consuming 1090 mg/day of supplemental vitamin C; 1000 mcg/day of 
supplemental vitamin B12; 800 mg/day of supplemental calcium; 10 mg/day of supplemental 
iron, and 550 mg/day of supplemental magnesium. The daily dose of magnesium (550 mg) that 
this patient reported taking was well above the tolerable upper intake level (UL) for magnesium, 
which is 350 mg/day. This patient was also taking Celebrex (an NSAID) daily, which could 
 55 
 
increase the risk for hyperkalemia. Additionally, this patient was consuming supplemental 
potassium daily, which could further add to the risk for hyperkalemia.  
Table 5.8: Case #2 of potential drug-nutrient interactions 
Sex Oral 
drugs 
Supp. 
Use 
Drug Nutrient Interaction Effect of 
Supplement Use 
F 18 10 Esomeprazole 
(PPI) 
Vitamin C 
Vitamin B12 
Calcium 
Iron 
Magnesium 
Risk for 
malabsorption.  
 
 
 
All nutrients 
supplemented. 
Supplemental 
magnesium over UL 
(550mg). 
   Celecoxib 
(NSAID) 
Potassium Risk for 
hyperkalemia 
80mg/day 
supplemental 
potassium 
 
 The third case (Table 5.9) was a 64-year-old female who reported the use of 15 oral drugs 
and 2 nutritional supplements. This patient was taking 4 types of drugs (a total of 6 different 
drugs) that had the potential to interact with one or more nutrients. Firstly, the patient was taking 
cetirizine (an H2 receptor antagonist) that has the potential to interact with both calcium and 
iron, with the possibility of malabsorption of both nutrients. Neither of the nutritional 
supplements that this patient was consuming contained calcium or iron. The patient was also 
taking diuretics, which had the potential to interact with one or more nutrients. This patient was 
taking both furosemide and hydrochlorothiazide, each of which could affect the status of 
calcium, potassium, magnesium, and sodium. This patient was being supplemented with 
potassium daily but was not taking any supplements containing calcium, magnesium, or sodium. 
Anticonvulsants can impact the status of folate and this patient was taking gabapentin and 
lamotrigine. Neither of the nutritional supplements that this patient was taking contained folate, 
 56 
 
likely placing the patient at increase risk of impaired folate status. Lastly, this patient was taking 
ranitidine, an antacid, which can affect the absorption of chromium. The patient was not taking 
any supplements that contained chromium. Overall, this patient was potentially at greater risk for 
malabsorption of calcium, iron, magnesium, sodium, folate, and chromium due to the types of 
medications that she was taking.  
The fourth case analyzed (Table 5.10) was a 74-year-old woman who reported taking 14 
oral drugs and 5 oral nutritional supplements. This patient was taking 6 types of drugs that had 
the potential to impact her nutrient status. In addition to pantoprazole (a PPI), celecoxib (an 
NSAID), docusate sodium (a laxative), sennosides/docusate (a laxative), gabapentin (an 
anticonvulsant), and hydrochlorothiazide (a diuretic), the patient was also consuming 
alendronate. Alendronate is a bisphosphonate that can cause calcium depletion. Of the nutritional 
supplements that this person reported taking, they were receiving 200 mg/day of supplemental 
calcium. Nutrients with the potential for interaction with her other medications included vitamin 
C, vitamin B12, vitamin E, vitamin K, iron, magnesium, potassium, and folate. This patient was 
not consuming supplemental vitamin B12, vitamin E, vitamin K, iron, potassium, folate, or 
sodium, likely putting her at increased risk of impaired nutrient status. 
 
 
 
. 
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Table 5.9: Case #3 of potential drug-nutrient interactions 
Sex Oral 
drugs 
Supp. 
Use 
Drug Nutrient Interaction Effect of 
Supplement 
Use 
F 15 2 Cetirizine (H2 
receptor antagonist) 
Calcium 
Iron 
Risk for 
nutrient 
malabsorption.  
No nutrient 
supplementation 
by patient 
   Furosemide (Loop 
diuretic) 
 
Calcium 
Potassium 
Magnesium 
Sodium 
 
Risk for nutrient 
depletion  
 
Potassium 
supplementation 
daily. No other 
nutrient 
supplementation 
by patient. 
   Hydrochlorothiazide 
(Thiazide diuretic) 
Calcium Risk for 
hypercalcemia 
No calcium 
supplementation 
by patient.  
   Gabapentin 
(anticonvulsant) 
Lamotrigine 
(anticonvulsant) 
Folate Risk for folate 
depletion 
No nutrient 
supplementation 
by patient. 
   Ranitidine (Antacid) Chromium Risk for 
malabsorption.  
No nutrient 
supplementation 
by patient. 
  
  
 
5
8
 
Table 5.10: Case #4 of potential drug-nutrient interactions 
Sex Oral 
Drugs 
Supp. 
Use 
Drug Nutrient Interaction Effect of Supplement Use 
F 
 
14 5 Pantoprazole (PPI) Vitamin C 
Vitamin B12 
Calcium 
Iron 
Magnesium 
Risk for nutrient 
malabsorption.  
 
No nutrient supplementation of 
vitamin B12 or iron by patient. 
   Alendronate 
(bisphosphonate) 
Calcium 
 
Calcium depletion.  200mg/day supplemental 
calcium. 
   Celecoxib (NSAID) Potassium Risk for hyperkalemia.  No potassium supplementation. 
   Docusate Na 
(Laxative) 
Sennosides/ 
Docusate (laxative) 
Vitamin E 
Vitamin K 
Calcium 
Potassium 
Magnesium 
Malabsorption.  No supplemental vitamin E, K, 
potassium. 
   Gabapentin 
(anticonvulsant) 
Folate 
 
Risk for folate 
depletion.  
No nutrient supplementation by 
patient. 
   Hydrochlorothiazide 
(Thiazide diuretic) 
Calcium 
Potassium 
Magnesium 
Sodium 
Risk for hypercalcemia 
and potassium, 
magnesium, sodium 
depletion. 
Calcium and magnesium 
supplementation daily. No other 
nutrient supplementation by 
patient. 
 59 
 
CHAPTER 6 
DISCUSSION 
6.1 Discussion 
The overarching aim of this research project was to identify initial data needed to 
implement nutritional interventions to medically complex patients, particularly to ensure the safe 
usage of vitamin and mineral supplements at the primary care level. Such intervention could aid 
in improving the health status of older adults with chronic disease. In addition, this project aimed 
to highlight the positive attributes that a collaborative interdisciplinary approach could bring to a 
pharmacist-led medication assessment centre, such as the integration of a dietitian into the 
assessment and counselling of high-risk patients. Thus, the purpose of this study was to assess 
the personal vitamin and mineral supplement use of older adults with complex medication use. 
Specifically, the three objectives of this study were to: 1) identify use and overuse of vitamin and 
mineral supplements; 2) learn the extent to which people were consuming supplemental nutrients 
from multiple sources; 3) investigate the potential for adverse drug-nutrient interactions. 
6.1.1 Demographics 
 For a patient chart to be included in this study and have their data extracted, the patient 
had to be 50 years of age or older at the time of their initial assessment and have at least one drug 
or supplement listed in their chart. Age was a component of the inclusion/exclusion criteria for 
this study because 50 is a pivotal age at which the recommended intake for many nutrients 
changes (Otten et al., 2006; Ross et al., 2011). Furthermore, an evaluation study (n = 173) of the 
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patient care clinic, the Medication Assessment Centre (MAC), that we used for the current study 
was completed in 2014/2015 and looked at demographic data that spanned all ages of patients 
(Jorgenson, Landry, & Lysak, 2016). Thus, the current study looked at a subpopulation, patients 
50 years of age and older. The current study (n = 229) found that patient ages ranged from 50-93 
years, with a mean and median age of 69 years. In 2014/2015, the average age of a patient 
attending the MAC was 64.8 years with ages ranging from 2-93 y (Jorgenson et al., 2016). As 
seen by comparing the size of the current study (n= 229) to that of the one completed in 2014/15 
(n = 173), the patient group at the MAC has grown significantly.   
 The current study looked at many patient characteristics that were also investigated in the 
study done by Jorgenson et al. (2016) such as gender, number of medical diagnoses, and number 
of medications recorded at first appointment. The current study found that 57.2% (n = 131) 
patients were female similar to the study by Jorgenson et al. (2016) who found 60.1% were 
female for all ages. Thus, as the patient population at the MAC has grown, the distribution 
between males and females has remained relatively stable. When Jorgenson et al. (2016) looked 
at the number of medical diagnoses reported by patients, they found that diagnoses ranges from 
1-16, with an average of 6.5 diagnoses per patient. Although the currently study only looked at 
older adults, we found that the reported number of health conditions in this group also ranged 
from 1-16, but had a lower average (4.8 conditions per patient). As for the number of 
medications recorded at the first appointment, the study by Jorgenson et al. (2016) included both 
drugs and supplements as the number of medications recorded at first appointment whereas the 
current study looked at drugs and supplements separately and then summed the groups to obtain 
a total product count per patient. We found that product use ranged from 1 - 45 products per 
patient, with an average of 9.8 and a median of 9 products per patient. The study by Jorgenson et 
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al. (2016) found a greater range (1-55) and average (13.8) for total product use, when compared 
to our study.  
6.1.2 Vitamin and Mineral Supplement Use 
 This study found that supplement use was prominent (76.9%) in a group of medically-
complex older adults, with 176 patients reporting use of at least one vitamin or mineral 
supplement (VMS) daily. VMS use did not vary significantly between sexes, with 77% of males 
(n = 76/98) and 76% of females (n = 100/131) reporting daily use. Although the current study 
did not find a significant difference in VMS use between sexes, a nationally representative 
Canadian study of supplement use in community-dwelling individuals found that VMS use was 
closely related to age and was significantly higher in females than males, both for overall use and 
for use in adults 50 years of age and older (Vatanparast, Adolphe, & Whiting, 2010).  
 Vitamin D was the most used supplement in the current study, with 64.6% of patients 
reporting the use of a vitamin D supplement daily. Of the reported supplement users in this 
study, 78.4% reported taking a vitamin D supplement daily. A multivitamin/mineral (MVM) 
product was the next most used supplement by this group, with 41.5% of the patients reporting 
daily use and 54% of supplement users reporting daily consumption. The third most used 
supplement in this study was vitamin C, with 22% of the patients and 29% of the supplement 
users reporting daily use. These results vary slightly from a study that looked at nationally-
representative data on supplement use of Canadians and found that vitamin D was the most 
common supplement used in women over the age of 50 years but for men of the same age group, 
vitamin C was the most commonly consumed supplement (Shakur, Tarasuk, Corey, & 
O’Connor, 2012). For all age groups, vitamin C was the most commonly used supplement, 
followed by vitamin D and a multivitamin/mineral product (Shakur et al., 2012).  
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Health Canada recommends that all adults over the age of 50 take a 400 IU supplement of 
vitamin D daily to ensure vitamin D adequacy (Health Canada, 2012). Furthermore, 
Osteoporosis Canada suggests 800-2000 IU/day of supplemental vitamin D to maintain vitamin 
D adequacy in older adults (Hanley et al., 2010). Despite these recommendations, the current 
study found that only 64.6% of patients consumed a vitamin D supplement of 400 IU or more per 
day. In comparison to other studies, this finding is relatively high. For example, a Canadian 
study of long term care (LTC) residents found that only 35.4% of residence (n = 189) took a 
vitamin D supplement daily (Viveky et al., 2012). A nationally representative study also found 
relatively low prevalence of vitamin D supplement use. Results showed that 28% of males and 
44% of females 51 years of age and older took supplemental vitamin D daily (Shakur, Tarasuk, 
Corey, & O’Connor, 2012).  The current study found that women were more likely to take a 
daily vitamin D supplement, when compared to men, with 67.9% of females and 60.2% of males 
reporting vitamin D supplement use on a daily basis. Despite the apparent difference in 
supplemental vitamin D use, the association between sex and supplemental vitamin D was not 
significantly associated.  
6.1.3 Overuse of Vitamin and Mineral Supplements 
 For the purpose of this study, overuse of vitamin and mineral supplementation was 
defined as intake at or above the Tolerable Upper Intake Level (UL). The current study 
investigated the overuse of vitamin and mineral supplements in a group of older adults with 
multiple morbidities and compared their intake to the UL to investigate overuse. Notably, the 
Dietary Reference Intakes, including the ULs are set for a healthy population and the effect of 
nutrient intake in excess of the UL in individuals with multiple morbidities is unknown. 
Presumably, medically-complex individuals may have a lower tolerance to the UL, based on 
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their individual medical conditions. Further research into ULs for groups with multiple 
morbidities is needed.  
 Overall, 70 participants (30.6%) in this study reported overuse of at least one 
supplemental nutrient. A nationally representative study that looked at diet and supplement 
intake found that Canadian adults did not exceed the UL from diet alone for any nutrient; but 
when supplements were considered, over 10% of some age and sex groups exceeded the UL for 
several nutrients (Shakur et al., 2012). The current study found that niacin (vitamin B3) was the 
most overused nutrient, with 26 patients (14.7% of supplement users) reporting daily intake of 
supplemental niacin that exceeded the UL. Of those who reported overuse of niacin supplements, 
the average intake was 155 mg/day, over four times the UL of 35 mg/day. Similarly, the study by 
Shakur et al. (2012) found that 50% of adult supplement users over the age of 50 years had a 
niacin intake above the UL. The UL for niacin only applies to synthetic forms of the nutrient and 
is based on the adverse effect of flushing (Otten, Pitzi Hellwig, & Meyers, 2006). In addition to 
flushing, side effects of large doses of niacin include vomiting, liver toxicity, blurred vision, and 
impaired glucose tolerance (Otten et al., 2006). It is likely that many patients in the current study 
were at greater risk for adverse effects from overuse, secondary to their medical complexity. For 
example, individuals suffering from liver dysfunction, diabetes, peptic ulcers, gout, cardiac 
arrhythmias, or inflammatory bowel disease are at an increased risk of observing adverse effects 
from niacin at or above the UL (Otten et al., 2006).  
 Magnesium was the second most overused nutrient in this study. Only pharmacological 
agents contribute to the UL for magnesium, meaning that intake from food is not a factor of 
consideration. The UL of 350 mg/day of magnesium was set based on several studies showing 
diarrhea when high doses of non-food sources of magnesium were consumed (Otten, Pitzi 
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Hellwig, & Meyers, 2006). In the current study, 23 patients consumed magnesium supplements 
at or over the UL of 350 mg/day, with an average intake of 586 mg of supplemental magnesium 
per day. When taken in very high doses, magnesium can cause metabolic alkalosis, hypokalemia, 
or a paralytic ileus (Otten et al., 2006). It is important to note that older adults are more likely to 
experience decreased magnesium absorption through the intestine and increased urinary 
magnesium excretion while individuals with impaired renal function are at a greater risk of 
experiencing magnesium toxicity from pharmacological sources (Otten et al., 2006). Although 
high doses of magnesium may prove to be beneficial for certain medical conditions, the age of 
patients in the current study suggests that they are at an increased risk for experiencing adverse 
side effects from their high doses of magnesium. Supplemental magnesium intake for this age 
group should be overseen by a health care professional to decrease the potential from adverse 
side effects, especially in patients who are taking acute doses of magnesium that exceed the UL.  
 Following niacin and magnesium, iron supplements were next most likely taken in doses 
that exceeded the UL by 14 patients (6.1%) in the current study. Unlike niacin and magnesium, 
dietary intake of iron contributes to the UL thus if dietary intake was considered in this study 
there would likely be higher intakes of total iron. The average intake of supplemental iron from 
the patients that exceeded the UL was 135 mg/day, substantially greater than the UL of 45 
mg/day. The UL for iron is based on gastrointestinal distress but some populations such as 
people with hemochromatosis, chronic alcoholism, or other liver disorders may not be protected 
by this UL (Otten et al., 2006). Individuals who follow a vegetarian diet may find it a challenge 
to consume adequate amounts of iron from their diet alone because the bioavailability of plant-
based sources of iron is approximately 10% (Otten et al., 2006). Data on dietary patterns or 
intake was not available in this study thus we cannot comment on the association between a 
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vegetarian diet and increased prevalence of iron supplement use. Data from a nationally-
representative study indicate that the use of supplements greatly increased the likelihood of 
exceeding the UL for many nutrients, including iron (Shakur, Tarasuk, Corey, & O’Connor, 
2012). Special recommendations exist for iron supplementation in men and postmenopausal 
women, suggesting that iron supplementation should be avoided in these groups because the 
relationship between excessive intake and heart disease and cancer is unclear (Otten et al., 2006). 
Based on the age of our study population, the women in our study were more likely to be 
postmenopausal. Of those who exceeded the UL for iron in this study, 7 were men and 7 were 
women who ranged from 54-86 years of age. 
 In Canada, vitamin D supplementation of 400 IU/day is recommended for all adults over 
the age of 50 years (Health Canada, 2012). Vitamin D supplements were overused by 13 patients 
(5.7%) in this study. Of the 13 patients, two consumed 4000 IU of vitamin D daily, which is 
equivalent to the UL. The average vitamin D intake from supplements alone, for those who 
exceeded the UL, was 5223 UL/day. One patient consumed 8000 IU daily, a dose that is double 
that of the UL. The UL for vitamin D is based on hypercalcemia, which is an indicator of vitamin 
D intoxication (Ross, Taylor, Yaktine, & Del Valle, 2011). Unfortunately, similar to the other 
nutrients, there is uncertainty surrounding the long-term effects of vitamin D consumption at or 
above the UL.  
Calcium is also a nutrient of concern for older adults. The recommended intake of 
calcium increases from 1000mg/day to 1200mg/day after the age of 70 years for males while this 
increase happens after the age of 50 for females (Ross, Taylor, Yaktine, & Del Valle, 2011). 
Based on these recommendations, older adults may be more inclined to consume a calcium 
supplement, potentially leading to overuse. In the current study, calcium supplement use was 
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common (21% of supplement users) but was only overused by two female patients in the study. 
Data from a nationally representative Canadian survey indicate that 15% of female supplement 
users who were over the age of 50 years exceeded the UL for calcium, from a combined intake 
of diet and supplements (Shakur, Tarasuk, Corey, & O’Connor, 2012). The UL for calcium is 
based on  the following indicators: hypercalcemia, hypercalciuria, vascular and soft tissue 
calcification, renal stone development, prostate cancer, interactions with iron and zinc, and 
constipation; with kidney stone formation being the key marker for older adults (Ross et al., 
2011). It is difficult to exceed the UL and experience the previously mentioned adverse effects 
from dietary calcium intake alone (Ross et al., 2011). People with multiple morbidities should be 
aware that renal failure or the use of thiazide diuretics put them at an increased risk of 
experiencing adverse effects from calcium (Otten, Pitzi Hellwig, & Meyers, 2006).  
 A total of 12 patients (5.2%) reported taking daily folate supplements at or above the UL 
of 1 mg/day. The average folate intake for these patients was 2.57 mg/day, more than double the 
UL for this age group. Folate from non-fortified food sources does not contribute to the UL, 
which was set based on the exacerbation of neuropathy in vitamin B12-deficient individuals 
(Otten et al., 2006). Essentially, excessive folate intake can mask a vitamin B12 deficiency, 
which if left untreated can lead to neurological damage (Otten et al., 2006). A study of 
nationally-representative Canadian survey data indicate that 3.3-4.2% of men and women over 
the age 50 years exceed the UL for folate when the use of dietary supplements was considered 
(Shakur, Garriguet, Corey, & O’Connor, 2010). The same study looked at dietary intake and 
concluded that there was minimal risk of exceeding the UL for folate, from fortified dietary 
sources alone (Shakur et al., 2010).  
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 For men and women over the age of 50 years, the UL for zinc is 40 mg/day (Otten et al., 
2006). Both dietary and supplemental sources of zinc contribute to the UL, which is based on a 
zinc-induced decrease in copper absorption (Otten et al., 2006). A total of 12 patients (5.2%) 
took zinc supplements in daily doses equal to or greater than the UL, with an average intake of 
60 mg/day. If dietary intake was a component of this study, it is likely that we would have seen a 
greater proportion of patients exceed the UL for zinc. A nationally representative study on 
Canadian community-dwelling adults found that 14% of adults over the age of 50 years exceeded 
the UL for zinc (Shakur, Tarasuk, Corey, & O’Connor, 2012). Although both dietary and 
supplemental intakes of zinc contribute to the UL, chronic intake of supplemental zinc can cause 
gastrointestinal distress, headaches, impaired immune function, and changes in cholesterol levels 
(Otten et al., 2006).  
 The UL for vitamin B6 is 100 mg/day, based on the critical adverse effect of sensory 
neuropathy (Otten et al., 2006). In the current study, vitamin B6 is the only nutrient that was 
consumed in amounts equal to the UL more frequently than in amounts exceeding the UL. A 
total of 11 patients (4.8%) consumed supplemental B6 at or in excess of the UL, with 6 patients 
reporting intake of 100 mg/day. Dietary vitamin B6 intake contributes the UL thus it is likely 
that the majority of these patients are actually exceeding the UL for vitamin B6. The largest dose 
of supplemental vitamin B6 in this group was 300 mg/day, which is well below the dose (2000 
mg/day chronic use) that has been shown to cause sensory neuropathy and skin lesions (Otten et 
al., 2006). Interestingly, 81.8% (n = 9/11) of patients who took supplemental vitamin B6 at or in 
excess of the UL reported use of a B complex supplement. A study of nationally-representative 
Canadian survey data found that less than 5% of adults over the age of 50 years had a vitamin B6 
intake that exceeded the UL when both dietary and supplement intake was considered (Shakur et 
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al., 2012). Despite the low prevalence of vitamin B6 overuse, the same study found that 26% of 
males and 31% of females over the age of 50 reported taking a vitamin B6-containing 
supplement on a daily basis (Shakur et al., 2012).  
 Despite being the third most consumed supplement of patients in this study, vitamin C 
was only taken in amounts equal to or greater than the UL by 3% of patients. The UL for vitamin 
C is 2000 mg/day, a value that is set based on osmotic diarrhea and gastrointestinal distress 
(Otten et al., 2006). The average intake of supplemental vitamin C for those patients who 
reported excess use was 3070 mg/day, approximately one and a half times the UL for this 
nutrient. One patient in the study reported a daily supplemental vitamin C intake of 5250 
mg/day. Adverse effects such as osmotic diarrhea and gastrointestinal distress have been 
documented with intakes greater than 3000 mg/day (Otten et al., 2006). The study by Shakur et 
al. (2012) had similar findings to our study, with high use (32% females; 38% males) of vitamin 
C supplements but low prevalence (<5%) of exceeding the UL for vitamin C. Lastly, one patient 
in the study exceeded the UL for manganese, reporting a daily intake of 30 mg/day. The UL for 
manganese is 11 mg/day, based on the critical outcome of neurotoxicity secondary to elevated 
blood manganese (Otten et al., 2006). 
6.1.4 Vitamin and Mineral Supplement Use from Multiple Sources 
 Patients in this study who reported daily use of supplements were likely to obtain their 
nutrient intake from two or more supplement products. Of the supplement users in this study, 
43.2% of them reported nutrient intake from more than one supplement. Overall, 33.2% of 
patients in this study consumed nutrients from two or more supplement sources. For example, a 
patient who took a multivitamin, vitamin D, and a magnesium supplement would have had intake 
of both vitamin D and magnesium from two sources as both nutrients are found in the 
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multivitamin product. An American study looked at data from 3469 adults over the age of 60 
years and found that 69% reported taking two or more dietary supplements daily (Gahche, 
Bailey, Potischman, & Dwyer, 2017). Furthermore, this study found that older adults who 
reported the use of three or more daily prescription drugs were more likely to take a dietary 
supplement (Gahche et al., 2017).  
 Of the 76 patients who reported nutrient consumption from more than one product, 
86.8% were consuming supplemental vitamin D from two or more sources. Furthermore, this 
group of supplement users consumed an average of 3.1 different nutrients from multiple 
supplement products. In this study, the vitamin D intake of 400 IU/day or more was significantly 
associated with nutrient intake from multiple sources (p < 0.001). Additionally, reporting uptake 
of nutrients from more than one supplement product was significantly associated with 
supplemental nutrient intake at or in excess of the UL (p < 0.001). Consuming supplemental 
nutrients from more than one source raises concerns as it is more likely for the patient to exceed 
the UL for a nutrient, as found in the current study and elsewhere (Viveky et al., 2012). Dietary 
intake should be taken into consideration when completing medication assessments for complex 
patients, especially in those who are reporting the use of multiple supplements, in order to 
mitigate the risks of supplement consumption in conjunction with medication use.  
6.1.5 Potential Drug-Nutrient Interactions 
 Drug-nutrient interactions are a concern for health care providers, especially when 
working with medically-complex patients such as those in the current study. Additionally, the 
multitude of factors that affect the likelihood of a drug-nutrient interaction occurring make it 
difficult for practitioners to mitigate all risks associated. A recent American study on supplement 
and drug use in 3469 older adults (over 60 years of age) concluded high (29%) use of dietary 
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supplements and concurrent use with prescription drugs (Gahche, Bailey, Potischman, & Dwyer, 
2017). Furthermore, a recent review found that the concurrent use of prescription drugs and 
dietary supplements is becoming increasingly common; thus there is growing risk of adverse 
effects from such interactions (Harris, Morrow, Titgemeier, & Goldberg, 2017; Qato et al., 2008; 
Qato, Wilder, Schumm, Gillet, & Alexander, 2016). As the uptake of prescription drugs (average 
6.5/patient) and supplements (average 2.4/patient) was high in this study population, the 
potential for drug-nutrient interactions was investigated through four case studies. These case 
studies were chosen based on the top drug users in this study.  
 The first case study investigated the potential for drug-nutrient interactions in a 53-year-
old male who reported the use of 18 drugs and no nutritional supplements, as seen in Table 5.7. 
This patient was taking three different drugs that had the potential to cause nutrient depletion 
including a laxative, proton pump inhibitor (PPI), and an H2 receptor antagonist. Overall, these 
three drugs had the potential to cause depletion of nine nutrients. Both the laxative and the 
proton pump inhibitor could cause calcium depletion (Heidelbaugh, 2013; Nelms, Sucher, Lacey, 
& Roth, 2011). As this patient was not consuming any supplemental nutrients, they were at 
greater risk of experiencing nutrient depletion from the drugs that they consume. The Dietary 
Reference Intakes (DRIs) are set for healthy populations and do not account for nutrient 
depletion cause by drugs (Otten, Pitzi Hellwig, & Meyers, 2006). Thus, this patient was 
potentially at risk for nutrient depletion, especially calcium. Iron, vitamin B12, calcium, and 
magnesium should all be monitored if PPI use is chronic as PPIs inhibit gastric acid secretion, 
decreasing the absorption of these nutrients (Heidelbaugh, 2013). Unfortunately, the clinical 
significance of PPI-induced nutrient depletion remains unclear in the literature (Heidelbaugh, 
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2013). Overall, risk of nutrient depletion for this patient could be mitigated through low-dose 
nutrient supplementation.  
 The second case study, shown in Table 5.8, was a 60-year-old female who also reported 
the use of 18 drugs, but took 10 nutritional supplements as well. Of the 18 drugs, one had the 
potential to deplete her nutrient status, while another could cause high potassium (hyperkalemia). 
As discussed in the first case, the use of a PPI has the potential to cause depletion of several 
nutrients including vitamin C, vitamin B12, calcium, iron, and magnesium. In this case, the 
patient was taking all potentially affected nutrients in supplemental form. This patient was taking 
550 mg/day of supplemental magnesium, a dose much greater than the UL, which may be 
justified by her use of a PPI. The non-steroidal anti-inflammatory drug (NSAID) that this patient 
was taking could potentially cause hyperkalemia. In addition to this risk, the patient was 
consuming additional potassium in her supplements, which could exacerbate this issue. Overall, 
this patient was potentially at risk for nutrient depletion of vitamins C and B12, calcium, iron, 
and magnesium secondary to her PPI use. She likely mitigated the potential for adverse nutrient 
depletion by consuming supplemental forms of the affected nutrients.  
 The third case study illustrated the concomitant drug and supplement use of a 64-year-old 
female, as shown in Table 5.9. She reported the use of 15 drugs and 2 supplements. Of the drugs 
that she reported using, five had the potential to cause nutrient depletion while one had the 
potential to cause hypercalcemia. Two of the drugs that this patient was consuming had the 
potential to cause calcium depletion. The H2 receptor antagonist and the loop diuretic that this 
patient took could cause nutrient depletion of calcium, iron, potassium, magnesium, and sodium 
(Nelms, Sucher, Lacey, & Roth, 2011). Of these nutrients, only potassium was being 
supplemented daily. Although this patient was not consuming any supplemental calcium, she 
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was on a thiazide diuretic which may cause excess calcium retention. It is possible that the use of 
a thiazide diuretic could decrease the impact of the potential drug-induced calcium depletion that 
was previously mentioned. Of note, this patient was on two anticonvulsant drugs which have the 
potential to cause folate depletion. Folate depletion from anticonvulsant drugs can be corrected 
through folate supplementation (Linnebank et al., 2011). Overall, this patient’s supplement use 
could be modified to aid in mitigating potential drug-related nutrient depletion.  
 The last case analyzed was of a 74-year-old female who reported taking 14 drugs and 4 
supplements daily. Seven of the drugs that she used had the potential to cause impair her nutrient 
status. As already discussed, the use of a PPI, NSAID, and anticonvulsant, can cause nutrient 
depletion. In total, this patient was taking four drugs, a PPI, bisphosphonate, and two laxatives, 
that could cause calcium depletion (Heidelbaugh, 2013; Nelms et al., 2011; Pronsky & Crowe, 
2012). Although she reported supplementing her dietary calcium intake with 200 mg of 
supplemental calcium daily, she was also on a thiazide diuretic which can potentially lead to 
hypercalcemia. It is possible that between her calcium supplement and the use of a thiazide 
diuretic, the risk of calcium depletion from the four other drugs was mitigated. Lastly, this 
patient was on a PPI, potentially placing her at greater risk for iron and vitamin B12 depletion 
(Heidelbaugh, 2013). As vitamin B12 stores take several years to deplete, her vitamin B12 status 
should be monitored if her use of a PPI is chronic. Overall, this case study along with #2 and #3 
highlight that despite the use of supplemental nutrients, if they are not systematically chosen then 
they may not aid in mitigating the potential risks associated with drug-induced nutrient 
depletions.  
 Overall, dietary Reference Values such as RDAs and ULs do not account for nutrient 
impairment (depletion or retention) that can be caused by drugs. Thus, individuals who are 
 73 
 
prescribed drugs that have the potential to have impaired nutrient status should be counselled on 
the appropriate use of nutritional supplements. Furthermore, as the literature does not focus on 
the effect of drugs on nutrient status,  this area requires further research (Péter et al., 2017). The 
above-mentioned case studies illustrate the need for further work in the area of drug-nutrient 
interactions that affect the nutrient status of patients. The development of a screening tool or 
checklist for healthcare providers would greatly aid in identifying and mitigating the risks 
associated with drug-induced altered nutrient status. Additionally, these cases highlight the need 
for interdisciplinary collaboration between healthcare practitioners, especially for medically-
complex patients.   
6.2 Limitations 
A limitation of the current study was that the data on drugs, supplements, and health 
conditions was self-reported. Although patients were asked to bring in the bottles for the drugs 
and supplements that they used, their actual usage was self-reported. A second limitation of this 
study was that many supplements were recorded in the medical chart without a brand name, thus 
standard formulations were used to collect data on supplemental nutrient intake. It is likely that 
this limitation had minimal impact on the study outcomes as the formulations for most vitamins 
and minerals are very similar. Lastly, no dietary intake or dietary assessment data were available, 
and as this study was retrospective in nature, information on diet could not be obtained. Thus, the 
study was only able to look at nutrient intake from supplements. As previously discussed, many 
ULs for nutrients consider dietary intake and it is likely that if dietary intake were to be factored 
in then more patients would have exceeded the UL. Further, for the drug-nutrient interactions 
where nutrient depletion or malabsorption was the main risk factor, this study was unable to 
comment on the impact of dietary intake on the potential interactions. Nonetheless, the 
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importance of monitoring supplement intake was highlighted through the high prevalence of use 
and frequency of consumption over the UL for several nutrients.  
6.3 Conclusion 
 A total of 229 patient charts were reviewed for this study, and we found that 76.9% of 
adults over the age of 50 reported consuming a vitamin or mineral supplement daily. Of these 
patients over the age of 50 years, only 64.6% reported taking a vitamin D supplement daily. 
Overuse of supplements was observed in 70 patients (30.6%) and niacin (vitamin B3) was taken 
in excess the most frequently (by 26 patients). Additionally, 43.2% of patients who reported 
daily supplement use were consuming the same nutrient(s) from more than one supplement. 
These factors, in combination with the potential for drug-nutrient interactions in this population, 
are cause for concern and suggest that an interdisciplinary approach to care would benefit this 
medically-complex group of patients. The addition of dietitian services to complex medication 
assessments would aid patients in achieving maximal benefit and minimal adverse effects from 
their vitamin and mineral supplement use.   
6.4 Future Research 
This study sought to identify data needed to investigate the potential for adverse drug-
nutrient interactions and was a hypothesis-generating study with the aim of identifying a possible 
prospective study. Future research should consider a prospective study of vitamin and mineral 
supplement use in a medically-complex group that also gathers dietary intake data. Such study 
would provide greater insight into drug-nutrient interactions and the effect that dietary intake can 
have in aiding or worsening the nutritional-impact of the interaction. Further, such a study could 
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collect data showing whether or not the patient actually experienced the drug-nutrient 
interaction. 
6.5 Implications for Practice 
This study highlights the importance of an interdisciplinary team approach to complex 
medication assessments. The case studies presented in this study highlight the potential 
interactions that could have been identified by health care professionals. The addition of a 
Registered Dietitian to a patient care clinic such as the Medication Assessment Centre would 
benefit patient care as they bring specialized knowledge in dietary intake and the role of 
supplements in individualized patient care. Furthermore, the data from this study can aid in the 
development of resources that would be aimed at maximizing the benefits of vitamin and mineral 
supplements while mitigating the potential effects related to overuse of supplements or drug-
nutrient interactions. 
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APPENDIX A 
Data Extraction Form  
Participant Code: ____________          Male / Female          Age: _______          Postal Code: ______________ 
Chronic Diseases/Health Conditions: 
o Cardiovascular Disease o Obesity 
o Hypertension o Cancer (specify: ________________________) 
o Osteoporosis  
o Diabetes o Other (specify: _________________________) 
 
Pill Count: 
Prescription Medications Dietary Supplements Over-the-Counter 
   
1. __________________________ 1. __________________________ 1. __________________________ 
2. __________________________ 2. __________________________ 2. __________________________ 
3. __________________________ 3. __________________________ 3. __________________________ 
4. __________________________ 4. __________________________ 4. __________________________ 
5. __________________________ 5. __________________________ 5. __________________________ 
6. __________________________ 6. __________________________ 6. __________________________ 
7. __________________________ 7. __________________________ 7. __________________________ 
8. __________________________ 8. __________________________ 8. __________________________ 
9. __________________________ 9. __________________________ 9. __________________________ 
10. _________________________ 10. _________________________ 10. _________________________ 
11. _________________________ 11. _________________________ 11. _________________________ 
12. _________________________ 12. _________________________ 12. _________________________ 
13. _________________________ 13. _________________________ 13. _________________________ 
14. _________________________ 14. _________________________ 14. _________________________ 
15. _________________________ 15. _________________________ 15. _________________________ 
16. _________________________ 16. _________________________ 16. _________________________ 
17. _________________________ 17. _________________________ 17. _________________________ 
18. _________________________ 18. _________________________ 18. _________________________ 
19. _________________________ 19. _________________________ 19. _________________________ 
20.__________________________ 20. _________________________ 20. _________________________ 
   
Notes: 
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________ 
 
